UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
___________________
FORM 6-K
__________________
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month
of March 2025
Commission File Number: 001-41524
___________________________________
Rentokil Initial plc
(Registrant’s name)
___________________________________
Compass House
Manor Royal
Crawley
West Sussex RH10 9PY
United Kingdom
(Address of principal executive office)
_____________________________________
Indicate by
check mark whether the registrant files or will file annual reports
under cover of Form 20-F or Form 40-F.
Form
20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(1): ☐
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T
Rule 101(b)(7): ☐
Final Results
dated 06 March 2025
|
|
2024 Preliminary
Results
Results in line with revised
guidance
North American review informs
revised branch and brand strategy. Integration on track for
completion end 2026.
Financial
Results
|
Adjusted Results
(AER)
|
|
Statutory
Results (AER)
|
£m
|
2024
£m
|
2023
£m
|
Change
%
|
2024
£m
|
2023
£m
|
Change
%
|
Revenue
|
5,436
|
5,375
|
1.1%
|
|
5,436
|
5,375
|
1.1%
|
EBITDA
|
1,177
|
1,228
|
(4.2%)
|
|
|
|
|
Operating
Profit
|
834
|
898
|
(7.0%)
|
|
549
|
625
|
(12.1%)
|
Operating Profit
margin
|
15.3%
|
16.7%
|
(1.4ppt)
|
|
10.1%
|
11.6%
|
(1.5ppt)
|
Profit before
Tax
|
703
|
766
|
(8.1%)
|
|
405
|
493
|
(17.9%)
|
Free Cash Flow
|
410
|
500
|
(18.0%)
|
|
|
|
|
Basic EPS
|
21.25p
|
23.19p
|
(8.4%)
|
|
12.17p
|
15.14p
|
(19.6%)
|
Diluted EPS
|
21.19p
|
23.08p
|
(8.2%)
|
|
12.14p
|
15.07p
|
(19.5%)
|
Dividend Per
Share
|
9.09p
|
8.68p
|
4.7%
|
|
9.09p
|
8.68p
|
4.7%
|
Net debt
|
(3,208)
|
(3,146)
|
(2.0%)
|
|
(3,208)
|
(3,146)
|
(2.0%)
|
|
|
|
|
|
|
|
|
|
Adjusted Results
(CER)
|
|
|
|
|
Revenue
|
5,587
|
5,375
|
3.9%
|
|
|
|
|
Operating
Profit
|
860
|
898
|
(4.2%)
|
|
|
|
|
Operating Profit
margin
|
15.4%
|
16.7%
|
(1.3ppt)
|
|
|
|
|
Profit before
Tax
|
731
|
766
|
(4.6%)
|
|
|
|
|
Andy Ransom,
Chief Executive of Rentokil Initial plc (“the
Company”), said:
“2024 was
a challenging year for the Group, with lower profits and margins,
delivered in line with our trading update in September. Good growth
in the International business (Organic Revenue growth 4.7%) was
held back by the performance in North America (Organic Revenue
growth 1.5%).
“The
Terminix integration is making good progress, with multiple
important milestones achieved, but executing it has clearly
impacted our North American business
performance.
“The
integration remains on track to be completed by the end of 2026.
Colleague and Customer retention across our NA business saw
encouraging improvements during 2024, and has also been trending
positively at the newly integrated branches.
“Our
sales and marketing initiatives to drive organic growth require
further refinement to deliver the required improvements in overall
lead generation and sales conversion, which will be a key focus in
2025. To address this, our revised branding strategy will see the
national focus for the Rentokil and Terminix brands supplemented by
additional prominence for our nine main regional brands. Alongside
this, we will use insights from our promising satellite branch
pilot to optimise the branch network size. We now expect that the
end state branch network (including satellites) is likely to exceed
500 locations. Post integration we expect to generate both market
beating growth and considerable cost efficiencies, with North
American margins exceeding 20%.
“We
continue to benefit from our diversified, global footprint and
resilient business model, in addition to our sustained focus on
customer service and investment in people, technology and
innovation. Present in c.90 countries and with industry leading
technology, we are a global leader in pest control and the largest
pest control operator in the US, which has demonstrated attractive
and sustained structural growth over time. With our enhanced scale,
brand portfolio and service offering, we remain confident in our
ability post the integration of Terminix to deliver sustained
growth.
“We
expect to achieve 2025 financial performance in line with market
expectations.”
2024 Financial Highlights (Unless
otherwise stated, all financials are presented at constant exchange
rates).
●
|
Group Organic
Revenue1
Growth of 2.8%, with the International
business up 4.7%.
|
●
|
North America Organic
Revenue growth of 1.5%, with 1.5% in Pest
Control.
|
●
|
Group Adjusted
Operating Margin of 15.4%2,
impacted by North America margin reduction to
17.1%.
|
●
|
Group Adjusted PBT at
AER of £703m, in line with revised
guidance.
|
●
|
Net debt to EBITDA at
2.9x as at 31 December 2024.
|
●
|
Recommended final
dividend 5.93p; total FY 24 dividend of 9.09p per share, c.5% year
on year increase.
|
2024 Strategic
Highlights
●
|
2024 delivered continued progress with Terminix
Integration
|
|
–
|
First Terminix branch systems
integration completed, covering 58 branches with Revenues of $373m
and c.1,000 service technicians. Over 250 branches in North America
now operate unified finance, HR, payroll, procurement, and sales
commission systems.
|
●
|
2024 North America RIGHT WAY 2 Growth Plan
progress
|
|
–
|
Colleague Retention +4.2% vs FY23
to 79.4%.
|
|
–
|
Customer Retention at over 81% in
Q4. FY24: 80.1% (FY23: 79.5%).
|
|
–
|
Work continues on improving sales
and marketing execution; leads and sales conversion still
lagging.
|
|
–
|
First satellite branches opened in
Q4: testing more local locations to drive greater customer
proximity.
|
●
|
Integration strategy review complete. Integration remains on track
to complete by end of 2026
|
|
–
|
Encouraging response from
colleagues and customers in initial fully migrated branches to pay
plan and rerouting pilot. At these locations, customer retention
increasing on pre-migration levels, while colleague retention has
remained in line with pre-migration levels.
|
|
–
|
Branch integration scheduled to
restart in early H2; c.100% branches complete by end
2026.
|
|
–
|
Revised brand strategy: focus on 9
regional brands, plus national Rentokil and Terminix
brands.
|
|
–
|
Revised branch strategy: end state
branch network now envisaged of over 500, including
satellites.
|
|
–
|
Significant 2024 additional
investments to drive revenue – brand awareness, lead
generation, sales infrastructure – offer partial opportunity
for redeployment, allowing 2025 revised strategies to be
funded.
|
|
–
|
Post 2026, completion of
integration is expected to deliver $100m cost reduction versus 2024
levels of cost, with branch right-sizing and improved route density
significantly improving technician efficiency.
|
|
–
|
Interrelationship of growth
investments, inflationary increases and cost synergies make net
synergies too subjective to disaggregate and report on. From 2027,
completion of integration activities expected to deliver North
American margins exceeding 20% from faster organic growth and
reduced costs. Previous FY 26 Group margin target
withdrawn.
|
●
|
Continued momentum in bolt on M&A. 36 businesses with revenues
of c.£140m in the year prior to purchase acquired for
£182m; strong pipeline of opportunities for attractive bolt-on
acquisitions being worked on.
|
2025 Outlook and
Q1 current trading
●
|
Despite Q1 year-to-date growth in
North America having been held back principally as a result of
continued weak lead generation, we expect to achieve FY 2025
results in line with market expectations.
|
●
|
2025 growth initiatives are fully
funded within the inflation adjusted 2024 cost base, with
reinvestments targeted to higher return activities including the
revised brand and branch strategy.
|
●
|
FY 2025 Adjusted free cash flow
conversion forecast at 80%, with modest balance sheet
deleveraging.
|
●
|
FX movements are expected to have a
headwind impact of $10m-$20m in 2025; US dollar reporting to
commence in 2025.
|
Re-presentation
of financial information in US dollars
As announced in July 2024, the
Group will change its presentation currency to US dollars for
reporting periods starting from 1 January 2025, as we believe that
this will provide better alignment of the reporting of performance
with business exposures.
For comparative purposes, the Group
has today published historical financial information re-presented
in US dollars on its IR website
(www.rentokil-initial.com/investors). The selected unaudited
information included in the document has been derived from the
consolidated financial statements and accounting records of the
Group for each of the years ended 31 December 2022, 31 December
2023 and 31 December 2024, and the six months ended 30 June
2024.
Enquiries:
Investors /
Analysts:
|
Peter Russell
|
Rentokil Initial
plc
|
07795 166506
|
Media:
|
Malcolm Padley
|
Rentokil Initial
plc
|
07788 978199
|
A management presentation and
Q&A for investors and analysts will be held today, 6 March 2025
from 9.15am at the Leonardo Royal London St Paul’s Hotel, 10
Godliman Street, London EC4V 5AJ. The event will also be available
via a live webcast. Dial-in details will be provided on the website
(https://www.rentokil-initial.com/investors.aspx). A recording will
be made available following the conclusion of the
presentation.
Notes
1 Organic
Revenue growth represents the growth in Revenue excluding the
effect of businesses acquired during the year. Acquired businesses
are included in organic measures in the year following acquisition,
and the comparative period is adjusted to include an estimated full
year performance for growth calculations (pro forma
revenue)
2 Excludes
costs to achieve which are one-off by nature
AER –
actual exchange rates; CER – constant 2023 exchange
rates
Non-IFRS
measures – This statement includes certain financial
performance measures which are not measures defined under
International Financial Reporting Standards (IFRS). These measures
include Adjusted Operating Profit, Adjusted Profit Before Tax,
Adjusted Profit After Tax, Adjusted EBITDA, Adjusted Interest,
Adjusted Earnings Per Share, Free Cash Flow, Adjusted Free Cash
Flow, Adjusted Free Cash Flow Conversion, Adjusted Effective Tax
Rate and Organic Revenue. Management believes these measures
provide valuable additional information for users of the financial
statements to aid better understanding of the underlying trading
performance. Adjusted Operating Profit, Adjusted Profit
Before/After Tax and Adjusted EBITDA exclude certain items that
could distort the underlying trading performance of the business.
Revenue and Adjusted Operating Profit are presented at CER unless
otherwise stated. An explanation of all the above non-IFRS measures
used along with reconciliation to the nearest IFRS measures is
provided in Use of Non-IFRS measures on page
16-22.
Summary of financial performance (at CER)
Regional Performance
|
Revenue
|
|
Adjusted
Operating Profit
|
|
2024
£m
|
2023
£m
|
Change
%
|
2024
£m
|
2023
£m
|
Change
%
|
North
America
|
|
|
|
|
|
|
|
Pest Control
|
3,236
|
3,201
|
1.1%
|
|
553
|
599
|
(7.5%)
|
Hygiene &
Wellbeing
|
111
|
105
|
5.5%
|
|
20
|
18
|
7.4%
|
|
3,347
|
3,306
|
1.3%
|
|
573
|
617
|
(7.1%)
|
|
|
|
|
|
|
|
|
International
|
|
|
|
|
|
|
|
Pest Control
|
1,172
|
1,085
|
8.0%
|
|
241
|
231
|
4.5%
|
Hygiene &
Wellbeing
|
820
|
753
|
8.8%
|
|
149
|
139
|
6.7%
|
France Workwear
|
237
|
221
|
7.1%
|
|
42
|
39
|
8.6%
|
|
2,229
|
2,059
|
8.2%
|
|
432
|
409
|
5.7%
|
|
|
|
|
|
|
|
|
Europe (incl.
LATAM)
|
|
|
|
|
|
|
|
Pest Control
|
551
|
516
|
6.6%
|
|
128
|
124
|
3.3%
|
Hygiene &
Wellbeing
|
364
|
344
|
5.9%
|
|
56
|
52
|
6.3%
|
France Workwear
|
237
|
221
|
7.1%
|
|
42
|
39
|
8.6%
|
|
1,152
|
1,081
|
6.5%
|
|
226
|
215
|
5.0%
|
|
|
|
|
|
|
|
|
UK &
Sub-Saharan Africa
|
|
|
|
|
|
|
|
Pest Control
|
206
|
195
|
5.5%
|
|
54
|
51
|
5.5%
|
Hygiene &
Wellbeing
|
231
|
195
|
18.5%
|
|
47
|
43
|
8.9%
|
|
437
|
390
|
12.0%
|
|
101
|
94
|
7.0%
|
|
|
|
|
|
|
|
|
Asia &
MENAT
|
|
|
|
|
|
|
|
Pest Control
|
276
|
250
|
10.4%
|
|
36
|
34
|
5.4%
|
Hygiene &
Wellbeing
|
92
|
89
|
3.0%
|
|
12
|
11
|
3.3%
|
|
368
|
339
|
8.4%
|
|
48
|
45
|
4.9%
|
|
|
|
|
|
|
|
|
Pacific
|
|
|
|
|
|
|
|
Pest Control
|
139
|
124
|
12.4%
|
|
23
|
22
|
7.7%
|
Hygiene &
Wellbeing
|
133
|
125
|
6.2%
|
|
34
|
33
|
5.5%
|
|
272
|
249
|
9.3%
|
|
57
|
55
|
6.4%
|
|
|
|
|
|
|
|
|
Central
|
11
|
10
|
7.8%
|
|
(138)
|
(121)
|
(14.1%)
|
Restructuring
costs
|
–
|
–
|
–
|
|
(7)
|
(7)
|
0.3%
|
Total at
CER
|
5,587
|
5,375
|
3.9%
|
|
860
|
898
|
(4.2%)
|
Total at
AER
|
5,436
|
5,375
|
1.1%
|
|
834
|
898
|
(7.0%)
|
Category Performance
|
Revenue
|
|
Adjusted
Operating Profit
|
|
2024
£m
|
2023
£m
|
Change
%
|
2024
£m
|
2023
£m
|
Change
%
|
Pest Control
|
4,408
|
4,286
|
2.9%
|
|
794
|
830
|
(4.2%)
|
Hygiene &
Wellbeing
|
931
|
858
|
8.4%
|
|
169
|
157
|
6.8%
|
France Workwear
|
237
|
221
|
7.1%
|
|
42
|
39
|
8.6%
|
Central
|
11
|
10
|
7.8%
|
|
(138)
|
(121)
|
(14.1%)
|
Restructuring
costs
|
–
|
–
|
–
|
|
(7)
|
(7)
|
0.3%
|
Total at
CER
|
5,587
|
5,375
|
3.9%
|
|
860
|
898
|
(4.2%)
|
Total at
AER
|
5,436
|
5,375
|
1.1%
|
|
834
|
898
|
(7.0%)
|
In order to
help understand the underlying trading performance, unless
otherwise stated, figures below are presented at constant exchange
rates.
Revenue
Group Revenue increased 3.9% to
£5,587m. Group Organic Revenue grew 2.8%. Group Revenue was up
1.1% to £5,436m at AER. Revenue growth in North America was up
1.3% (Organic Revenue +1.5%). North America saw a 90bps
quarter-on-quarter improvement in regional Organic Revenue growth
in Q4 (1.4% in Q3, 2.3% in Q4). The International business drove
Revenue up 8.2% for the full year with a good contribution from all
regions. Europe, the Group’s second largest region, was up by
6.5%; UK & Sub-Saharan Africa was up 12.0%; the Pacific was up
9.3%; and Asia & MENAT was up 8.4%.
Our Pest Control category grew
Revenue by 2.9% (2.5% Organic) to £4,408m, mainly from price
increases. Hygiene & Wellbeing Revenue increased by 8.4% (3.1%
Organic) to £931m, led in general by resilient demand for
washroom services. Strong progression in both volume and price were
reflected in the contribution from our France Workwear business,
with Revenue up by 7.1% to £237m (7.1%
Organic).
Revenue (£m
at CER)
|
H1
|
H2
|
Full
Year
|
Group
|
2,756
|
2,831
|
5,587
|
North
America
|
1,662
|
1,685
|
3,347
|
International
|
1,088
|
1,141
|
2,229
|
Organic
Growth
|
H1
|
H2
|
Full
Year
|
Group
|
2.8%
|
2.8%
|
2.8%
|
North
America
|
1.3%
|
1.8%
|
1.5%
|
International
|
5.2%
|
4.3%
|
4.7%
|
Profit
Adjusted Operating Profit reduced
by 4.2% during the year to £860m, impacted by the performance
in North America. As stated in the Company’s September
Trading Update, in North America there was a drop-through impact on
profit from below expected organic revenue growth and from
significant in-year cost investments to drive revenue, resulting in
a 130bps decrease year on year in Group Adjusted Operating Margin
to 15.4%. Within business categories, Adjusted Operating Margin for
Pest Control was 18.0% (FY 23: 19.3%). Hygiene & Wellbeing
Adjusted Operating Margin was 18.1% (FY 23: 18.4%), and France
Workwear was 17.7% (FY 23: 17.5%).
Adjusted Profit before Tax (at AER)
of £703m, which excludes one-off and adjusting items and
amortisation costs, decreased by 8.1%. Adjusted interest of
£138m at actual exchange rates was £3m lower year on
year. One-off and adjusting items (operating) at AER of £86m
includes £59m (FY 23: £81m) of integration costs related
to the Terminix acquisition (“Costs to Achieve’’)
and £9m (FY 23: £13m) of other M&A costs. Statutory
Operating Profit at AER was £549m (FY 23: £625m).
Statutory profit before tax at AER was £405m (FY 23:
£493m).
Adjusted
Operating Profit (£m at CER)
|
H1
|
H2
|
Full
Year
|
Group
|
455
|
405
|
860
|
North
America
|
310
|
263
|
573
|
International
|
208
|
224
|
432
|
Adjusted
Operating Profit Margin
|
H1
|
H2
|
Full
Year
|
Group
|
16.5%
|
14.3%
|
15.4%
|
North
America
|
18.6%
|
15.6%
|
17.1%
|
International
|
19.1%
|
19.6%
|
19.3%
|
Cash (at AER)
Net cash flows from
operating activities were £678m. Free Cash Flow of £410m
was £90m lower than in FY 23 due to reduced profitability.
There was a £15m outflow (FY 23: £11m) from one-off and
adjusting items (non-cash).
The Group had a £105m working
capital outflow in FY 24. Capital expenditure of £215m was
incurred in the period (FY 23: £211m). Lease payments of
£145m were down 4.0% reflecting the start of integration work
on branch restructuring.
Cash interest payments of
£144m were £22m lower than in the prior year, reflecting
higher interest rates on investment income and lower swap payments
due to a weaker US dollar. Cash tax payments for the period were
£87m, a decrease of £13m compared with the corresponding
period last year reflecting lower profits in North America,
combined with one-off tax refunds. Adjusted Free Cash Flow
Conversion was 80.0%, in line with guidance.
Cash spend on current and prior
year acquisitions was £172m, dividend payments were £229m
and the cash impact of one-off and adjusting items was £77m,
largely related to Terminix integration costs.
Regional performance review
North America
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
3,260
|
-1.4%
|
3,347
|
1.3%
|
1.5%
|
Operating
Profit
|
418
|
-14.5%
|
430
|
-12.2%
|
|
Adjusted Operating
Profit
|
558
|
-9.5%
|
573
|
-7.1%
|
|
Adjusted Operating
Margin
|
17.1%
|
-1.6%
|
17.1%
|
-1.6%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
North
America
|
1.5%
|
1.0%
|
1.4%
|
2.3%
|
1.5%
|
North America
Pest Control
|
1.5%
|
0.7%
|
1.4%
|
2.6%
|
1.5%
|
North America
Pest Control Services
|
1.0%
|
1.5%
|
1.4%
|
1.5%
|
1.4%
|
North America includes Pest Control
and Hygiene & Wellbeing.
North America Pest Services is Pest
Control excluding products/distribution, brand standards, lake and
vector.
2024
Performance
Full year Revenue was up 1.3%, with
Organic Revenue up 1.5%. There was an improved end to the year with
a 90bps quarter-on-quarter gain in regional Organic Revenue growth
in Q4 (1.4% in Q3, 2.3% in Q4), resulting in H2 Organic Revenue
growth of 1.8%, ahead of revised guidance of
c.1%.
Adjusted Operating Profit of
£573m, down 7.1%, reflects the combined impact of below plan
expectation revenue growth and from significant in year cost
investments to drive revenue. Consequently, despite continued good
price realisation, Adjusted Operating Margin in North America
declined to 17.1%. Operating Profit was £418m at
AER.
We are seeing ongoing success with
our recruiting, training and retention initiatives. Total North
America colleague retention increased to 79.4% (FY 23: 75.2%),
driven by improvement in frontline technician roles (+4.3ppts to
76.0%) and sales roles (+6.4ppts to 72.8%), and in both new
colleagues (0-12 months) and longer tenured (> 1yr) colleagues.
As a result of the improvement in new colleague retention, we have
100 more sellers entering 2025 in their second year versus their
first year of sales in 2024. Since the date of acquisition,
retention at Terminix has grown from 62.4% to 76.3%, an increase of
13.9ppts. Total customer retention in North America increased to
80.1% (FY 23: 79.5%). Following incremental improvement through the
year, there was a positive step change into year end with the three
best months of customer retention all recorded in Q4, each above
81%. Customer satisfaction was also positive, with an improved
overall Net Promoter Score of +53.3.
North American bolt-on M&A
programme continued, with the purchase of 13 businesses with
combined revenues of c.£69m in the year prior to purchase. We
continue to selectively pursue high quality M&A assets in the
North America region.
There was further progress on
legacy termite warranty obligations, with total open warranty
claims reducing by 20% on the prior year and by 72% since 2019.
Total pending litigated cases reduced by 41% in 2024 as the Company
continues to resolve legacy claims.
Right Way 2: Our
2024 Plan to drive Enhanced Organic Growth
Through the year we have been
optimising processes to increase overall lead volume and improve
lead quality. In March 2024, we launched the new ‘Terminix
It’ brand marketing campaign aimed at increasing awareness of
our Terminix brand and strengthening our top of funnel marketing.
This delivered a noticeable improvement in brand favourability
– with unaided Terminix brand awareness at its highest level
since 2021. A key focus in 2024 has been digital marketing, given
the significance of the digital channel for new customer
acquisition in the residential and termite pest control markets. We
are particularly focused on our organic lead capability, including
enhancing the content on our websites to align with AI-generated
search answers, in order to improve our search engine ranking over
time. However, there is still significant work to be done to
improve our lead generation.
We’ve made strong progress in
securing five-star reviews from our customers, which recognise high
service levels and serve as a critical component of Internet search
visibility. Five-star reviews for Terminix increased by 150% in the
year to 44,000. In parallel, we have augmented our paid search
strategies to generate higher quality leads. This includes refining
our bidding strategy for critical search terms.
We have leveraged technician leads
through our Trusted Advisor programme, creating a complementary
stream of lead generation. We continue to enhance our approach with
better data reporting, increased focus at a branch management level
and training for all new technicians as part of their on-boarding.
The participation rate for the Trusted Advisor programme increased
from 40% at the start of the year to 50% among Terminix
technicians, and from c.57% to c.73% among Rentokil
technicians.
In 2025, we will deploy enhanced
customer segmentation to effectively leverage media channels and
will integrate service demand forecasting by location into our
customer targeting. Once the sales team has sold the lead, it is
important that the technician completes the work order quickly. We
delivered consistent work order completion rates in 2024 of c.97%,
and in 2025 are aiming to reach 98%.
We will continue to focus heavily
on organic lead generation, as well as improve our sales conversion
and overall sales effectiveness, which will take time to fully
materialise. We invested significant additional sales and marketing
resources in 2024, which will continue into 2025. We believe we
have invested sufficient new resources to drive the enhanced level
of organic growth we are targeting, and during 2025 we will
continue to monitor and scrutinise the effectiveness of the 2024
investments, and where appropriate reprioritise them to higher
return activities, to optimise the return opportunity on that
investment.
2024 IT Systems
Migration
The IT systems integration has
proceeded to plan. Prior to the integration period, the region had
highly fragmented IT infrastructure with more than 70 systems and
multiple vendors. We now have a single back office IT set-up in
place, and ‘Best of Breed’ branch systems have been
selected and are being delivered.
We harmonised the multiple business
processes in H1, and in H2 started branch systems and data
migration. 58 branches, 987 service technicians, and $373 million
in revenue were successfully transitioned onto the unified
Rentokil-Terminix systems platform. Including the heritage Rentokil
network a total of over 250 branches in North America now operate
on our end-state IT systems suite. The migration has increased the
percentage of service technicians using PestPac and the ServiceTrak
app from c.40% at the start of the year to c.49% by year-end. A
structured approach ensures continued progress and alignment with
our strategic goals.
Employee feedback on the process to
date has been positive, highlighting the effectiveness of
pre-migration preparation, training, communication, and go-live
support.
2024 Technician
Rerouting and New Pay Plan Piloting
In Q4 2024 we commenced technician
rerouting and piloting of our new sales and service pay plans,
initially covering nine branches encompassing over 250 technicians
and c.40 sales colleagues. These rerouting and pay plans revision
efforts were executed to plan with minimal disruption to
operations. At these locations customer retention has increased on
pre-migration levels. Colleague retention has also remained strong,
in line with pre-migration levels. The second branch cluster of 41
branches with 1,000 technicians, has also recently completed. This
means that around 15 per cent of the Terminix branch network has
now been fully integrated.
Q1 2025 Terminix Integration review
As announced in October 2024,
during the first quarter of 2025 we have been reviewing the
progress made to date with the integration and the priorities for
its next phase. The review has helped us to enhance our Right Way 2
growth plan with respect to both our brand and branch strategies
and our customer retention and customer experience strategy, and to
review the best way to monitor ongoing cost saving
opportunities.
The full branch integration process
is planned to restart in early H2 2025.
Enhancing
Customer Retention and Customer Experience
Strategy
Our customer retention rates have
been stable to slightly improved through the course of the year. In
2024, we strengthened our account management teams, added new
senior customer experience experts and 40 new Customer Save team
members, and instated new retention strategies ranging from the
acquisition of more retainable customers and improving the
first-year experience through to minimising technician rotation and
optimising complaints management. We are also increasing our use of
data to better understand and seek to address the drivers of
customer retention and churn.
Optimising Brand strategy: Our revised
branding strategy will see the maintenance of a national focus for
the Rentokil and Terminix brands. However, there will be an
additional focus on our well-known regional brands, rather than
merging them over time with Terminix, giving us 9 regional core
brands. Smaller local brands will be co-branded or merged. This
will allow us to optimise the return opportunity we generate from
our advertising spend and increase the overall share of voice of
our brands.
Optimising Branch strategy: In Q4 2024
we commenced the piloting of satellite branches. Ten sites in key
metro areas were active as at the end of 2024, and we currently
have 22 in operation. These smaller branches are fully branded and
operational but have a low cost to operate. They serve as localised
hubs with active facilities, staffed with sales, administrative,
and customer support teams.
While the pilot is still not
complete, initial findings are positive, driving digital leads and
being recognised by search engines as local points of presence that
increase our digital footprint. Subject to continued progress with
this pilot, we believe a branch network combining larger,
traditional sites and smaller satellites will serve us well. Based
on our current branch network and mapping of an optimal footprint
for lead generation, we currently estimate that by the end of 2026
we will have a network of over 500 branches, including satellite
branches, versus our previous target of 400. In addition, we have
over 100 franchised owned and operated Terminix branches in the
US.
A portion of current investment
deployed during 2024 but not driving optimal effectiveness and
efficiency will be redirected to our enlarged brand and branch
strategies.
Cost savings and margin opportunity
We continued to achieve cost
synergies in 2024, whilst also continuing our significant
investments behind salary and benefit harmonisation, safety,
innovation and IT, and we saw another year of inflation in the cost
base.
During 2024 we made significant
in-year sales and marketing investments focused on driving revenue,
including behind brand awareness, lead generation and sales
infrastructure. A portion of the investment behind these
opportunities is not driving optimal effectiveness and efficiency
and in 2025 will be redirected to fund the new strategies we will
be deploying in respect of our enhanced brand strategy and our
enlarged branch strategy.
During 2025 we expect further
inflation but do not anticipate the need for additional investments
over those which were made in 2024.
Three years post the acquisition
announcement of Terminix, and going forward we will not report
separately on net synergy delivery. Disaggregating investments and
inflationary cost increases from synergistic cost savings over
multiple years is now overly subjective.
We remain confident that, from the
end of 2026, when we expect integration to be complete, significant
operational cost savings will be achieved, in line with initial
expectations of gross synergies. Branch integration and improved
route density will significantly improve technician efficiency. The
post 2026 cost reduction is estimated as a $100m reduction from the
2024 spend level.
From 2027, we expect that delivery
of these cost savings, together with an improved organic growth
rate post integration, will allow the North American business to
achieve operating profit margins above 20%. We are retiring the
previous Group Adjusted Operating Margin target of greater than 19%
by 2026.
Total one-time integration costs to
achieve (cash and non-cash) from the start of the integration to
the end of 2024 were $248m. The total remaining one-time costs to
achieve in 2025 to 2026 are expected to be
c.$100m.
The North
America leadership team has been significantly strengthened with
recent appointments:
Alain Moffroid, Interim North America CEO,
appointed Feb 2025. Alain was appointed to the role in Q1
2025 after the announced departure of Brad Paulsen. Alain is a
highly experienced leader in the Company with twelve years’
experience leading residential and commercial pest control
businesses, together with 23 years with Unilever in senior
leadership roles. As Group Chief Commercial Officer Alain has been
working closely with the North American business on delivering
their strategy focused on customer experience and retention,
digital and innovation programmes.
Aaron Coley, Chief Financial Officer, joined
Dec 2024. Aaron brings over 25 years of financial experience
to the role, including 14 years as CFO for companies at various
stages of transition. Most recently, he served as CFO for a
transportation and logistics company listed on
Nasdaq.
International
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
2,165
|
5.1%
|
2,229
|
8.2%
|
4.7%
|
Operating
Profit
|
339
|
-1.9%
|
346
|
+0.2%
|
|
Adjusted Operating
Profit
|
420
|
2.9%
|
432
|
5.7%
|
|
Adjusted Operating
Margin
|
19.4%
|
-0.4%
|
19.3%
|
-0.5%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
International
|
5.6%
|
4.9%
|
4.5%
|
4.1%
|
4.7%
|
Europe (incl. LATAM)
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
1,114
|
3.1%
|
1,152
|
6.5%
|
5.0%
|
Operating
Profit
|
170
|
-6.2%
|
175
|
-3.9%
|
|
Adjusted Operating
Profit
|
219
|
1.8%
|
226
|
5.0%
|
|
Adjusted Operating
Margin
|
19.6%
|
-0.3%
|
19.6%
|
-0.3%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
Europe (incl.
LATAM)
|
6.2%
|
5.3%
|
4.9%
|
4.0%
|
5.0%
|
The region enjoyed another good
performance in 2024, driven by both volume and pricing, and with a
strong contribution from Pest Control and Workwear. Revenue grew by
6.5% to £1,152m (5.0% Organic). Revenue growth in Pest Control
was 6.6%, supported by key markets including Germany, Benelux,
Spain and Italy. Hygiene & Wellbeing grew Revenue by 5.9% with
softer performance in Dental offset by strength in Specialist
Hygiene and Ambius where we continue to see significant
opportunity. France Workwear delivered another excellent year with
Revenue up 7.1%.
Adjusted Operating Profit in the
region grew by 5.0% to £226m, benefiting from pricing
discipline. Adjusted Operating Margin was down by 30bps to 19.6%.
In Europe, margin was stable, however there was a margin reduction
in LATAM, where adverse weather impacted the shipping fumigation
business. Operating Profit reduced by 6.2% to £170m at AER.
Customer retention has remained strong at 88.3% (FY 23: 88.4%.) A
focus on sales retention, including recruitment, onboarding and
early days retention led to best-in-class colleague retention rates
of 90.4% (FY 23: 90.4%).
In Europe and LATAM, 12 business
acquisitions (9 in Europe and 3 in LATAM) were completed in total
with revenues of £20m in the year prior to
purchase.
UK & Sub-Saharan Africa
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
435
|
11.5%
|
437
|
12.0%
|
4.3%
|
Operating
Profit
|
99
|
17.8%
|
100
|
18.2%
|
|
Adjusted Operating
Profit
|
100
|
6.7%
|
101
|
7.0%
|
|
Adjusted Operating
Margin
|
23.1%
|
-1.0%
|
23.0%
|
-1.1%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
UK &
Sub-Saharan Africa
|
4.1%
|
6.1%
|
4.2%
|
2.9%
|
4.3%
|
Revenue for the region increased by
12.0% (4.3% Organic), with Pest Control Revenue growth of 5.5% and
Hygiene & Wellbeing Revenue growth of
18.5%.
Regional Adjusted Operating Profit
increased by 7.0% to £101m. Operating Profit was up 17.8% to
£99m at AER. Adjusted Operating Margin decreased by 110bps to
23.0%, impacted largely by the acquisition of the lower margin
specialist hygiene company DCUK. The region delivered a price
performance that mitigated cost increases, alongside a consistently
strong customer service environment. Customer retention for the
full year was roughly stable at 86.0% (FY 23: 86.9%). Colleague
retention was up strongly to 86.8% (FY 23:
83.3%).
2024 was the UK’s biggest
ever year for innovations. 39 solutions in total were launched,
ranging from new additions to our suite of smart monitoring devices
and non-toxic wasp traps through to new air scenting products with
patented technology.
Two business acquisitions were
completed (both within the UK) with revenues of £31m in the
year prior to purchase.
Asia & MENAT
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
354
|
4.2%
|
368
|
8.4%
|
5.4%
|
Operating
Profit
|
24
|
-26.9%
|
25
|
-23.2%
|
|
Adjusted Operating
Profit
|
46
|
1.0%
|
48
|
4.9%
|
|
Adjusted Operating
Margin
|
12.9%
|
-0.4%
|
12.9%
|
-0.4%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
Asia &
MENAT
|
4.3%
|
5.2%
|
6.5%
|
5.5%
|
5.4%
|
Revenue rose by 8.4%, of which 5.4%
was Organic. Pricing was complemented with volume growth, as
markets overall remained structurally supportive. The performance
was led by India and Indonesia, which both sustained high
single-digit organic growth. In India, good progress was made in
integrating the pest control company Hi-Care, acquired in the first
half of the year. In MENAT, regional conflict held back the final
quarter performance in the Lebanon market, but we are seeing a
prompt recovery.
Adjusted Operating Profit in Asia
& MENAT increased 4.9% to £48m and Adjusted Operating
Margin was down 40bps to 12.9% as a result of additional growth
investment. Operating Profit decreased by 26.9% to £24m at
AER. Customer retention increased to 80.7% (FY 23: 78.7%). Regional
operations have benefited from an increased colleague retention
rate of 93.3% (FY 23: 92.0%). The region acquired five businesses
with total revenues in the year prior to purchase of
£12m.
Pacific
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
262
|
5.3%
|
272
|
9.3%
|
3.2%
|
Operating
Profit
|
45
|
-3.3%
|
47
|
0.4%
|
|
Adjusted Operating
Profit
|
55
|
2.5%
|
57
|
6.4%
|
|
Adjusted Operating
Margin
|
21.1%
|
-0.6%
|
21.1%
|
-0.6%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
Pacific
|
7.3%
|
1.2%
|
0.6%
|
4.2%
|
3.2%
|
Revenue increased by 9.3% to
£272m, with Organic Revenue growth of 3.2%. Pest Control
revenue growth was 12.4%, driven by sustained momentum in both
contract and jobbing work, despite weather related challenges
affecting rural and trackspray operations during the year. Hygiene
& Wellbeing revenue grew by 6.2%, with strong demand for
Ambius’ services continuing. Adjusted Operating Profit in the
Pacific was up by 6.4% to £57m, with an Adjusted Operating
Margin of 21.1%. Operating Profit decreased by 3.3% to £45m at
AER. Customer retention remained strong at 86.6% (FY23: 86.5%),
while colleague retention improved to 80.2% (FY23: 77.5%), with
positive momentum observed in the second half of the year. The
region acquired four businesses with total revenues in the year
prior to purchase of £8m.
Category performance review
Pest Control
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
4,287
|
0.1%
|
4,408
|
2.9%
|
2.5%
|
Operating
Profit
|
560
|
-13.7%
|
573
|
-11.6%
|
|
Adjusted Operating
Profit
|
773
|
-6.7%
|
794
|
-4.2%
|
|
Adjusted Operating
Margin
|
18.0%
|
-1.3%
|
18.0%
|
-1.3%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
Pest
Control
|
2.7%
|
1.7%
|
2.3%
|
3.3%
|
2.5%
|
Our Pest Control business is the
largest operator in both the US, the world’s biggest pest
control market, and the world, with a presence in 88 countries. The
business sustained growth in the year, underpinned by the critical
nature of its services and with a strong contribution from the
International business. Overall Revenue was up by 2.9% (2.5%
Organic) to £4,408m. Organic Revenue growth in the
International business of 5.3%, in line with our medium-term range
for Pest Control of between 4.5-6.5%, offset more modest North
America Organic Revenue growth of 1.5%. There was a drag from the
North America business on Adjusted Operating Profit, down by 4.2%
to £794m, resulting in an Adjusted Operating Margin for the
Pest Control category of 18.0%. Operating Profit decreased by 13.7%
to £560m at AER. Pest Control represented 79% of Group Revenue
and 79% of Group Adjusted Operating Profit.
We acquired 24 pest control
businesses in the period, with revenues in the year prior to
acquisition of £90m.
Hygiene & Wellbeing
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
908
|
5.7%
|
931
|
8.4%
|
3.1%
|
Operating
Profit
|
157
|
5.4%
|
161
|
8.0%
|
|
Adjusted Operating
Profit
|
164
|
4.2%
|
169
|
6.8%
|
|
Adjusted Operating
Margin
|
18.1%
|
-0.3%
|
18.1%
|
-0.3%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
Hygiene &
Wellbeing
|
3.8%
|
5.0%
|
2.9%
|
1.0%
|
3.1%
|
Rentokil Initial offers a wide
range of hygiene and wellbeing services. Inside the washroom we
provide hand hygiene (soaps and driers), air care, in-cubicle
(feminine hygiene units), no-touch products and digital hygiene
services. In addition to core washroom hygiene, we deliver
specialist hygiene services such as clinical waste management.
We’re also improving the customer experience through premium
scenting, plants, air quality monitoring and green
walls.
Hygiene & Wellbeing Revenue
increased by 8.4% to £931m. Organic Revenue growth was 3.1%,
Q4 organic growth was held back by 190bps quarter on quarter owing
to strong prior year comparatives from large projects in Ambius
North America and Covid-related credits in the UK. We see the main
opportunities for future growth in our Hygiene & Wellbeing
category as being core washrooms, premises hygiene, including air
care, and enhanced environments. In 2024, Organic Revenue growth in
core washrooms was 3.1%, while organic growth in premises and
enhanced environments was 3.7%. Adjusted Operating Profit was up by
6.8% to £169m, with Adjusted Operating Margin down 30bps to
18.1%. Operating Profit was up 5.4% to £157m at AER. For FY24,
Hygiene & Wellbeing represented 17% of Group Revenue and 17% of
Group Adjusted Operating Profit.
We acquired 12 Hygiene and
Wellbeing companies with revenues of c.£50m in the year prior
to purchase.
France Workwear
|
2024
AER
£m
|
AER
Growth
|
2024
CER
£m
|
CER
Growth
|
Organic
Growth
|
Revenue
|
230
|
4.3%
|
237
|
7.1%
|
7.1%
|
Operating
Profit
|
41
|
9.0%
|
42
|
12.0%
|
|
Adjusted Operating
Profit
|
41
|
5.7%
|
42
|
8.6%
|
|
Adjusted Operating
Margin
|
17.7%
|
+0.2%
|
17.7%
|
+0.2%
|
|
Organic
Growth
|
Q1
|
Q2
|
Q3
|
Q4
|
Full
Year
|
France
Workwear
|
7.7%
|
7.4%
|
7.4%
|
6.1%
|
7.1%
|
Strong new business sales
performance, including account gains and upselling, resulted in
another strong contribution from our France Workwear business where
Revenue rose by 7.1% to £237m, all from organic growth.
Inflation was successfully mitigated with price increases. Adjusted
Operating Profit growth increased by 8.6%. Operating Profit was up
9.0% to £41m at AER. The business has benefited from continued
strong colleague retention rates.
Continued strength of Bolt-on M&A
We acquired 36 new businesses,
comprising 24 in Pest Control and 12 in Hygiene & Wellbeing for
a total consideration of £182m, with total revenues of
£140m in the year prior to purchase. We added 13 new
businesses in North America during the period with £69m
revenues acquired, 12 deals in Europe inc. LATAM (revenues of
£20m in the year prior to purchase), two deals in the UK
&SSA region (revenues of £31m in the year prior to
purchase), five deals in Asia and MENAT (revenues of £12m in
the year prior to purchase) and 4 deals in the Pacific region
(revenues of £8m in the year prior to
purchase).
M&A remains central to our
strategy for growth. We will continue to seek attractive bolt-on
deals, both in Pest Control and Hygiene & Wellbeing, to build
density in existing and new markets. Our pipeline of prospects
remains strong and our current guidance on spend on M&A for FY
25 is c.$250m.
Employer of Choice (EOC)
Rentokil Initial is committed to
being a world-class Employer of Choice, with colleague safety and
the attraction, recruitment and retention of the best people from
the widest possible pool of talent, being key business objectives
globally.
In 2024, colleague retention
increased globally by 2.4ppts to 86.6%. Total service technician
retention for the Group was up 2.4ppts to 85.6%, while total sales
colleague retention was up 4.6ppt to 82.0%. All Regions except
Europe improved retention year on year, led by Asia at 93.3%.
Europe nevertheless also continued to record a world class
retention rate at 92.3%. Our North American region increased
colleague retention by 4.2ppts. This has been achieved through a
wide-ranging programme including: the launch of a retention
dashboard and manager training; monitoring for potential issues
before escalation; additional mentoring resources; and an enhanced
new hire and onboarding experience.
Innovation and Technology
We lead our industry in the use of
digital technologies in pest control, and we are continuing to
build upon this competitive advantage. Our smart technology is
providing more remote monitoring solutions and increased
transparency of data.
The digital Pest agenda moved
further forward in 2024. An additional 127,000 PestConnect devices,
which offer 24/7 monitoring, were installed in customers’
premises, and we now have a total of 500,000 devices installed. We
have 13 countries where connected devices now account for more than
10% of the commercial portfolio. In the UK, PestConnect accounts
for c.20% of the Company’s commercial pest control contracted
revenue. We continue to roll out smarter solutions. Our new
PestConnect Optix utilises AI and camera technology to identify
individual rodents. It’s available in the UK with deployments
in the Netherlands, France, Spain and the Middle East
underway.
In the year, North America also saw
the launch of our proprietary EcoCatch fly control solution for
commercial customers, as well as the continued rollout of our
Lumnia LED flying insect control range.
Financial
review
Central and
regional overheads
Central and regional overheads of
£138m (£137m at AER) were up £17m at CER (£16m
at AER) on the prior year (FY 23: £121m at CER and AER)
predominantly as a result of inflationary increases and increased
IT investment.
Restructuring
costs
With the exception of integration
costs for significant acquisitions, the Company reports
restructuring costs within Adjusted Operating Profit. Costs
associated with significant acquisitions are reported as one-off
and adjusting items and excluded from Adjusted Operating Profit.
Restructuring costs of £7m (at CER and AER) were in line with
the prior year (FY 23: £7m at CER and AER). They consisted
mainly of costs in respect of initiatives focused on our North
American transformation programme.
Interest (at
AER)
Adjusted interest of £138m at
actual exchange rates includes £98m of annualised interest
charges relating to financing of the Terminix transaction,
£24m of lease interest charges and a £46m offsetting
reduction from the impacts of hyperinflation and net interest
received. In the year, hyperinflation of £7m at AER was
£4m lower than the prior year (FY 23: £11m) due to
devaluation of the Argentinian peso. Cash interest in FY 24 was
£144m (FY 23: £166m) reflecting higher interest rates on
investment income and lower swaps payments due to a weaker US
dollar.
In Appendix 1 we have shown a
summary P&L interest table demonstrating how the components of
our financing drive interest costs and incomes and the expected
range for 2025 at average exchange rates. Changes in variable
interest rates, exchange rates and CPI rates in hyper-inflationary
economies during 2025 will impact the reporting of interest costs
for 2025.
Tax
The income tax charge for the
period at actual exchange rates was £98m on the reported
profit before tax of £405m, giving an effective tax rate (ETR)
of 24.2% (FY 23: 22.7%). The Group’s ETR before amortisation
of intangible assets (excluding computer software), one-off and
adjusting items and the net interest adjustments for FY 24 was
23.8% (FY 23: 23.8%). This compares with a blended rate of tax for
the countries in which the Group operates of 25.3% (FY 23:
25.1%).
Net debt and
cash flow
|
Year to Date
|
£m at actual exchange
rates
|
2023
FY
£m
|
2023 FY
£m
|
Change
£m
|
Adjusted Operating
Profit
|
834
|
898
|
(64)
|
Depreciation
|
308
|
300
|
8
|
Other
|
35
|
30
|
5
|
Adjusted EBITDA
|
1,177
|
1,228
|
(51)
|
One-off and adjusting items
(non-cash)
|
(15)
|
(11)
|
(4)
|
Working capital
|
(105)
|
(47)
|
(58)
|
Movement on
provisions
|
(60)
|
(56)
|
(4)
|
Capex –
additions
|
(215)
|
(211)
|
(4)
|
Capex –
disposals
|
4
|
14
|
(10)
|
Capital of lease payments and
initial direct costs incurred
|
(145)
|
(151)
|
6
|
Interest
|
(144)
|
(166)
|
22
|
Tax
|
(87)
|
(100)
|
13
|
Free Cash Flow
|
410
|
500
|
(90)
|
Acquisitions
|
(172)
|
(242)
|
70
|
Disposal of companies and
businesses
|
–
|
19
|
(19)
|
Dividends
|
(229)
|
(201)
|
(28)
|
Cash impact of one-off and
adjusting items
|
(77)
|
(107)
|
30
|
Other
|
–
|
(6)
|
6
|
Debt related cash
flows
|
|
|
|
Cash outflow on settlement of debt
related foreign exchange forward contracts
|
(9)
|
(3)
|
(6)
|
Net investment in term
deposits
|
(1)
|
–
|
(1)
|
Debt repayments
|
(369)
|
–
|
(369)
|
Debt related cash
flows
|
(379)
|
(3)
|
(376)
|
|
|
|
|
Net decrease in cash and cash
equivalents
|
(447)
|
(40)
|
(407)
|
Cash and cash equivalents at the
beginning of the year
|
832
|
879
|
(47)
|
Exchange losses on cash and cash
equivalents
|
(13)
|
(7)
|
(6)
|
Cash and cash equivalents at end of
the financial year
|
372
|
832
|
(460)
|
Net decrease in cash and cash
equivalents
|
(447)
|
(40)
|
(407)
|
Debt related cash
flows
|
379
|
3
|
376
|
IFRS 16 liability
movement
|
4
|
3
|
1
|
Debt acquired
|
(9)
|
(1)
|
(8)
|
Bond interest
accrual
|
(2)
|
(1)
|
(1)
|
Foreign exchange translation and
other items
|
13
|
169
|
(156)
|
(Increase)/decrease in net
debt
|
(62)
|
133
|
(195)
|
Opening net
debt
|
(3,146)
|
(3,279)
|
133
|
Closing net
debt
|
(3,208)
|
(3,146)
|
(62)
|
Funding
As at 31 December 2024, the Group
had liquidity headroom of £1,196m, including £799m ($1bn)
of undrawn revolving credit facility, with a maturity date of
October 2028 and £40m ($50m) term loan facility maturing May
2025. The net debt to EBITDA ratio was 2.9x at 31 December 2024 (31
December 2023: 2.8x). The net debt to Adjusted EBITDA ratio was
2.7x at 31 December 2024 (31 December 2023:
2.6x)
Dividend
The Board is recommending a final
dividend in respect of 2024 of 5.93p per share, payable to
shareholders on the register at the close of business on 4 April
2025, to be paid on 14 May 2025. This equates to a full-year
dividend of 9.09p per share, up 4.7% year on year, in line with the
Company’s progressive dividend policy. The last day for DRIP
elections is 22 April 2025.
Technical
guidance update for FY 25
As the Group is moving to US Dollar
reporting from 1 January 2025, technical guidance is provided in
the new reporting currency..
P&L
●
|
Restructuring costs: $10m; and One
offs and Adjusting items excl. Terminix: c.$15m
|
●
|
Terminix integration Costs to
Achieve*: c.$55-65m
|
●
|
P&L adjusted interest costs:
c.$190m-$200m, incl. $5m-$10m of hyperinflation (at
AER)
|
●
|
Estimated Adjusted Effective Tax
Rate: 25%-26%
|
●
|
Share of Profits from Associates:
c.$8m-$10m
|
●
|
Impact of FX within range of c.-$10
to -$20m**
|
●
|
Intangibles amortisation:
$190m-$200m
|
Cash
●
|
One-off and adjusting items:
c.$70m-$80m
|
●
|
Working Capital: c.$75m-$85m
outflow and provision payments of $80m-$90m
|
●
|
Capex excluding right of use (ROU)
asset lease payments: $300m-$310m
|
●
|
Cash interest:
c.$185m-$195m
|
●
|
Cash tax payments:
$140m-$150m
|
●
|
Anticipated spend on M&A in
2025 of c.$250m
|
*
Reported as one-off and adjusting items and excluded from Adjusted
Operating Profit and Adjusted PBTA;
**
Based on maintenance of current FX rates
Appendix 1 – Adjusted
Interest1
|
Amount
’m
|
Rate
|
Fixed/Floating
|
2024
AER
£m
|
|
2025
AER
$m
|
Bonds and
swaps
|
|
|
|
|
|
|
EUR
|
400
|
0.95%
|
Fixed
|
–
|
|
–
|
EUR
|
600
|
0.88%
|
Fixed
|
–
|
|
–
|
EUR
|
600
|
0.50%
|
Fixed
|
–
|
|
–
|
EUR
|
850
|
3.88%
|
Fixed
|
15
|
|
19
|
EUR
|
600
|
4.38%
|
Fixed
|
24
|
|
29
|
GBP
|
400
|
5.00%
|
Fixed
|
20
|
|
26
|
Amortised Cost
|
|
|
Fixed
|
2
|
|
2
|
Swaps
|
|
3.53% (avg)
|
Fixed
|
44
|
|
43
|
Total
|
1,850
|
|
|
105
|
|
119
|
Term
Loan
|
|
|
|
|
|
|
USD
|
700
|
5%-6%
|
Float
|
32
|
|
10
|
|
|
|
|
|
|
|
Lease Interest
|
|
|
Float
|
25
|
|
33
|
Other Interest
|
|
|
Float
|
19
|
|
49
|
Total
Other
|
|
|
|
44
|
|
82
|
|
|
|
|
|
|
|
Finance
Cost2
|
|
|
|
181
|
|
212
|
|
|
|
|
|
|
|
Interest
received
|
|
|
|
(36)
|
|
(13)
|
Hyper-Inflation
|
|
|
|
(7)
|
|
(6)
|
Finance
Income3
|
|
|
|
(43)
|
|
(19)
|
|
|
|
|
|
|
|
Adjusted
Interest
|
|
|
|
138
|
|
193
|
|
|
|
|
|
|
|
Adjusting items
|
|
|
|
|
|
|
Amortisation of discount on legacy
provisions2
|
|
10
|
|
13
|
Gain on hedge accounting recognised
in finance income/cost3
|
3
|
|
–
|
2024 average FX rate for
£/€: 1.1818 and £/$: 1.2773
1. For a full reconciliation of
statutory interest measures to adjusted interest, please see
non-IFRS measures section on page 16-22 below
2. 2024 Finance Costs totalled
£197m. See note C8
3. 2024 Finance Income totalled
£(46)m See note C9.
Use of Non-IFRS
Measures
Reconciliation of
non-IFRS measures to the nearest IFRS
measure
The Group uses a number of non-IFRS
measures to present the financial performance of the business.
These are not measures as defined under IFRS, but management
believes that these measures provide valuable additional
information for users of the Financial Statements, in order to
better understand the underlying trading performance in the year
from activities that will contribute to future performance. The
Group’s internal strategic planning process is also based on
these measures and they are used for management incentive purposes.
They should be viewed as complements to, and not replacements for,
the comparable IFRS measures. Other companies may use similarly
labelled measures which are calculated differently from the way the
Group calculates them, which limits their usefulness as comparative
measures. Accordingly, investors should not place undue reliance on
these non-IFRS measures.
The following sets out an
explanation and the reconciliation to the nearest IFRS measure for
each non-IFRS measure.
Constant exchange
rates (CER)
Given the international nature of
the Group’s operations, foreign exchange movements can have a
significant impact on the reported results of the Group when they
are translated into sterling (the presentation currency of the
Group). In order to help understand the underlying trading
performance of the business, revenue and profit measures are often
presented at constant exchange rates. CER is calculated by
translating current-year reported numbers at the full-year average
exchange rates for the prior year. It is used to give management
and other users of the accounts clearer comparability of underlying
trading performance against the prior period by removing the
effects of changes in foreign exchange rates. The major exchange
rates used for 2024 are £/$ 1.2773 (2023: 1.2441) and
£/€ 1.1818 (2023: 1.1503). Comparisons are with the year
ended 31 December 2023 unless otherwise stated.
Organic Revenue
Growth
Acquisitions are a core part of the
Group’s growth strategy. The Organic Revenue Growth measures
(absolute and percentage) are used to help investors and management
understand the underlying performance, positive or negative, of the
business, by identifying Organic Revenue Growth excluding the
impact of Acquired Revenue. This approach isolates changes in
performance of the Group that take place under the Company’s
stewardship, whether favourable or unfavourable, and thereby
reflects the potential benefits and risks associated with owning
and managing a professional services business.
Organic Revenue Growth is
calculated based on year-over-year revenue growth at CER to
eliminate the effects of movements in foreign exchange
rates.
Acquired Revenue represents a
12-month estimate of the increase in Group revenue from each
business acquired. Acquired Revenue is calculated as: (a) the
revenue from the acquisition date to the year end in the year of
acquisition in line with IFRS 3; and (b) the pre-acquisition
revenues from 1 January up to the acquisition date in the year of
acquisition. The pre-acquisition revenue is based on the previously
reported revenues of the acquired entity and is considered to be an
estimate.
In the year a business is acquired,
all of its revenue reported under (a) above is classified as
non-organic growth. In the subsequent first full financial year
after acquisition, Organic Revenue Growth is calculated for each
acquisition as the reported revenue less Acquired
Revenue.
At a Group level, calculating
Organic Revenue Growth therefore involves isolating and excluding
from the total year-over-year revenue change: (i) the impacts from
foreign exchange rate changes; (ii) the growth in revenues that
have resulted from completed acquisitions in the current period;
and (iii) the estimate of pre-acquisition revenues from each
business acquired. The sum of (ii) and (iii) is equal to the total
Acquired Revenues for all acquisitions. The calculated Organic
Revenue is expressed as a percentage of prior year revenue. Prior
year revenue is not ‘pro-forma’ adjusted in the
calculation, as any such estimated adjustments would have an
immaterial impact.
If an acquisition is considered to
be a material transaction, such as the Terminix acquisition in
October 2022, the above calculation is amended in order to give a
‘pro-forma’ view of any Organic Revenue Growth for the
full financial year in the year of acquisition, as if the
acquisition had been part of the Group from the beginning of the
prior year. The pro-forma calculation is completed using
pre-acquisition revenues to normalise current and prior periods as
shown in the table below. These revenue normalisations are
considered estimates, and ensure that the potentially larger
Organic Revenue Growth is measured over a denominator that includes
the material acquisition. The same adjustments are made to our
North America and Pest Control segment revenues for 2023 as a
result of the material Terminix acquisition.
While management believes that the
methodology used in the calculation of Organic Revenue is
representative of the performance of the Group, the calculations
may not be comparable with similarly labelled measures presented by
other publicly traded companies in similar or other
industries.
|
North
America
£m
|
Europe
(incl.
LATAM)
£m
|
UK
&
Sub-
Saharan
Africa
£m
|
Asia
&
MENAT
£m
|
Pacific
£m
|
Central
and
regional
£m
|
Total
£m
|
2023 Revenue
|
3,306
|
1,081
|
390
|
339
|
249
|
10
|
5,375
|
2023 Revenue from closed
business1
|
(45)
|
–
|
–
|
–
|
–
|
–
|
(45)
|
Normalised 2023 Revenue –
base for Organic Revenue Growth percentage
|
3,261
|
1,081
|
390
|
339
|
249
|
10
|
5,330
|
Revenue from 2024 acquisitions (at
2023 CER)²
|
22
|
10
|
24
|
8
|
4
|
–
|
68
|
Revenue from 2023 acquisitions (at
2023 CER)³
|
15
|
5
|
6
|
2
|
11
|
–
|
39
|
Organic Revenue Growth 2024 (at
2023 CER)4
|
49
|
56
|
17
|
19
|
8
|
1
|
150
|
2024 Exchange
differences
|
(87)
|
(38)
|
(2)
|
(14)
|
(10)
|
–
|
(151)
|
2024 Revenue (at
AER)
|
3,260
|
1,114
|
435
|
354
|
262
|
11
|
5,436
|
Organic Revenue
Growth %
|
1.5%
|
5.0%
|
4.3%
|
5.4%
|
3.2%
|
7.8%
|
2.8%
|
1.
The adjustment removes revenue from 1 April 2023 to 31 December
2023 from the Paragon distribution business closed with effect from
1 April 2024.
2. Revenue from completed
acquisitions in the current period.
3. Revenue from each business
acquired by the Group in the previous financial year through to the
12-month anniversary of the Group’s
ownership.
4.
Organic Revenue Growth includes Organic Revenue Growth for all
entities in the Group as at 31 December
2023.
|
North
America
£m
|
Europe
(incl.
LATAM)
£m
|
UK &
Sub-
Saharan
Africa
£m
|
Asia&
MENAT
£m
|
Pacific
£m
|
Central
and
regional
£m
|
Total
£m
|
2022 Revenue
|
1,849
|
941
|
365
|
321
|
227
|
11
|
3,714
|
Adjustment for Terminix
pre-acquisition 2022 Revenue¹
|
1,310
|
23
|
–
|
–
|
–
|
–
|
1,333
|
Normalised 2022 Revenue –
base for Organic Revenue Growth percentage
|
3,159
|
964
|
365
|
321
|
227
|
11
|
5,047
|
Revenue from 2023 acquisitions (at
2022 CER)²
|
33
|
7
|
15
|
6
|
14
|
–
|
75
|
Revenue from 2022 acquisitions (at
2022 CER)³
|
25
|
27
|
1
|
7
|
4
|
–
|
64
|
Organic Revenue Growth 2023 (at
2022 CER)4
|
97
|
80
|
13
|
23
|
16
|
(1)
|
228
|
2023 Exchange
differences
|
(8)
|
3
|
(4)
|
(18)
|
(12)
|
–
|
(39)
|
2023 Revenue (at
AER)
|
3,306
|
1,081
|
390
|
339
|
249
|
10
|
5,375
|
Organic Revenue
Growth %
|
3.0%
|
8.3%
|
3.4%
|
7.1%
|
6.8%
|
(4.4)%
|
4.5%
|
1. The adjustment brings in 2022
pre-acquisition revenue back to the first day of the prior
financial period for the acquired Terminix
entities.
2. Revenue from completed
acquisitions in the current period.
3. Revenue from each business
acquired by the Group in the previous financial year through to the
12-month anniversary of the Group’s
ownership.
4.
Organic Revenue Growth includes Organic Revenue Growth for all
entities in the Group as at 31 December
2022.
Adjusted
expenses and profit
measures
Adjusted expenses and profit
measures are used to give investors and management a further
understanding of the underlying profitability of the business over
time by stripping out income and expenses that can distort results
due to their size and nature. Adjusted profit measures are
calculated by adding the following items back to the equivalent
IFRS profit measure:
●
|
amortisation and impairment of
intangible assets (excluding computer
software);
|
●
|
one-off and adjusting items;
and
|
●
|
net interest
adjustments.
|
Intangible assets (such as customer
lists and brands) are recognised on acquisition of businesses
which, by their nature, can vary by size and amount each year.
Capitalisation of innovation-related development costs will also
vary from year to year. As a result, amortisation of intangibles is
added back to assist with understanding the underlying trading
performance of the business and to allow comparability across
regions and categories (see table on page 31).
One-off and adjusting items are
significant expenses or income that will have a distortive impact
on the underlying profitability of the Group. Typical examples are
costs related to the acquisition of businesses, gain or loss on
disposal or closure of a business, material gains or losses on
disposal of fixed assets, adjustments to legacy environmental and
legacy termite liabilities, and payments or receipts as a result of
legal disputes. An analysis of one-off and adjusting items is set
out below.
Net interest adjustments are other
non-cash, or one-off and adjusting accounting gains and losses,
that can cause material fluctuations and distort understanding of
the performance of the business, such as amortisation of discount
on legacy provisions and gains and losses on hedge
accounting.
Adjusted expenses are one-off and
adjusting items, and Adjusted Interest. Adjusted profit measures
used are Adjusted Operating Profit, Adjusted Profit Before and
After Tax, and Adjusted EBITDA. Adjusted Earnings Per Share is also
reported, derived from Adjusted Profit After
Tax.
One-off and
adjusting items
An analysis of one-off and
adjusting items is set out below.
|
One-off and
adjusting items
cost/(income)
£m
|
One-off and
adjusting items
tax impact
£m
|
One-off and
adjusting items
cash
(outflow)/inflow
£m
|
2022
|
|
|
|
Acquisition and integration
costs
|
5
|
(2)
|
(13)
|
Fees relating to Terminix
acquisition
|
68
|
(4)
|
(38)
|
Terminix integration
costs
|
62
|
(14)
|
(32)
|
UK pension scheme – return of
surplus
|
–
|
–
|
22
|
Other
|
1
|
–
|
2
|
Total
|
136
|
(20)
|
(59)
|
2023
|
|
|
|
Acquisition and integration
costs
|
13
|
(2)
|
(13)
|
Fees relating to Terminix
acquisition
|
1
|
–
|
(25)
|
Terminix integration
costs
|
81
|
(21)
|
(74)
|
Other
|
3
|
(1)
|
5
|
Total
|
98
|
(24)
|
(107)
|
2024
|
|
|
|
Acquisition and integration
costs
|
9
|
(3)
|
(15)
|
Terminix integration
costs
|
59
|
(15)
|
(60)
|
Other
|
18
|
(5)
|
(2)
|
Total
|
86
|
(23)
|
(77)
|
Adjusted
Interest
Adjusted Interest is calculated by
adjusting the reported finance income and costs by net interest
adjustments (amortisation of discount on legacy provisions, and
foreign exchange and hedge accounting
ineffectiveness).
|
2024
AER
£m
|
2023
AER
£m
|
Finance
cost
|
197
|
189
|
Finance
income
|
(46)
|
(48)
|
Add back:
|
|
|
Amortisation of discount on legacy
provisions
|
(10)
|
(11)
|
Foreign exchange and hedge
accounting ineffectiveness
|
(3)
|
11
|
Adjusted
Interest
|
138
|
141
|
Adjusted
Operating Profit
Adjusted Operating Profit is
calculated by adding back one-off and adjusting items, and
amortisation and impairment of intangible assets to operating
profit.
|
2024
£m
|
2023
£m
|
Operating
profit
|
549
|
625
|
Add back:
|
|
|
One-off and adjusting
items
|
86
|
98
|
Amortisation and impairment of
intangible assets¹
|
199
|
175
|
Adjusted
Operating Profit (at AER)
|
834
|
898
|
Effect of
foreign exchange
|
26
|
–
|
Adjusted
Operating Profit (at CER)
|
860
|
898
|
1.
Excluding computer software.
Adjusted Profit
Before and After
Tax
Adjusted Profit Before Tax is
calculated by adding back net interest adjustments, one-off and
adjusting items, and amortisation and impairment of intangible
assets to profit before tax. Adjusted Profit After Tax is
calculated by adding back net interest adjustments, one-off and
adjusting items, amortisation and impairment of intangible assets,
and the tax effect on these adjustments to profit after
tax.
2024
|
|
IFRS
measures
£m
|
Net
interest
adjustments
£m
|
One-off
and
adjusting
items
£m
|
Amortisation
and impairment
of
intangibles1
£m
|
Non-IFRS
measures
£m
|
|
Profit before
income tax
|
405
|
13
|
86
|
199
|
703
|
Adjusted
Profit Before Tax
|
Income tax
expense
|
(98)
|
(3)
|
(23)
|
(43)
|
(167)
|
Tax on Adjusted
Profit
|
Profit for the
period
|
307
|
10
|
63
|
156
|
536
|
Adjusted Profit
After Tax
|
2023
|
|
IFRS
measures
£m
|
Net
interest
adjustments
£m
|
One-off
and
adjusting
items
£m
|
Amortisation
andimpairment
of
intangibles1
£m
|
Non-IFRS
measures
£m
|
|
Profit before income
tax
|
493
|
–
|
98
|
175
|
766
|
Adjusted Profit Before
Tax
|
Income tax
expense
|
(112)
|
(2)
|
(24)
|
(44)
|
(182)
|
Tax on Adjusted
Profit
|
Profit for the
period
|
381
|
(2)
|
74
|
131
|
584
|
Adjusted Profit After
Tax
|
1.
Excluding computer software.
EBITDA and
Adjusted EBITDA
EBITDA is calculated by adding back
finance income, finance cost, share of profit from associates net
of tax, income tax expense, depreciation, amortisation and
impairment of intangible assets, and other non-cash expenses to
profit for the year. Adjusted EBITDA is calculated by adding back
one-off and adjusting items to EBITDA.
|
2024
£m
|
2023
£m
|
Profit for the
period
|
307
|
381
|
Add back:
|
|
|
Finance income
|
(46)
|
(48)
|
Finance cost
|
197
|
189
|
Share of profit from associates net
of tax
|
(7)
|
(9)
|
Income tax
expense
|
98
|
112
|
Depreciation
|
308
|
300
|
Other non-cash
expenses
|
35
|
30
|
Amortisation and impairment of
intangible assets¹
|
199
|
175
|
EBITDA
|
1,091
|
1,130
|
One-off and adjusting
items
|
86
|
98
|
Adjusted
EBITDA
|
1,177
|
1,228
|
1.
Excluding computer software.
Adjusted
Earnings Per Share
Basic earnings per share is
calculated by dividing the profit attributable to equity holders of
the Company by the weighted average number of shares in issue
during the year, and is explained in Note 6 to the Financial
Statements. Adjusted Earnings Per Share is calculated by dividing
adjusted profit from continuing operations attributable to equity
holders of the Company by the weighted average number of ordinary
shares in issue and is shown below.
For Adjusted Diluted Earnings Per
Share, the weighted average number of ordinary shares in issue is
adjusted to include all potential dilutive ordinary shares. The
Group’s potentially dilutive ordinary shares are explained in
Note 6 to the Financial Statements.
|
2024
£m
|
2023
£m
|
Profit
attributable to equity holders of the Company
|
307
|
381
|
Add back:
|
|
|
Net interest
adjustments
|
13
|
–
|
One-off and adjusting
items
|
86
|
98
|
Amortisation and impairment of
intangibles1
|
199
|
175
|
Tax on above items2
|
(69)
|
(70)
|
Adjusted profit
attributable to equity holders of the Company
|
536
|
584
|
|
|
|
Weighted average number of ordinary
shares in issue (million)
|
2,521
|
2,516
|
Adjustment for potentially dilutive
shares (million)
|
7
|
11
|
Weighted average
number of ordinary shares for diluted earnings per share
(million)
|
2,528
|
2,527
|
|
|
|
Basic Adjusted Earnings Per
Share
|
21.25p
|
23.19p
|
Diluted Adjusted Earnings Per
Share
|
21.19p
|
23.08p
|
1. Excluding computer
software.
2. The tax effect on add-backs is
as follows: one-off and adjusting items £23m (2023:
£24m); amortisation and impairment of intangibles £43m
(2023: £44m); and net interest adjustments £3m (2023:
£2m).
Adjusted cash
measures
The Group aims to generate
sustainable cash flow in order to support its acquisition programme
and to fund dividend payments to shareholders. Management considers
that this is useful information for investors. Adjusted cash
measures in use are Free Cash Flow, Adjusted Free Cash Flow, and
Adjusted Free Cash Flow Conversion.
Free Cash
Flow
Free Cash Flow is measured as net
cash flows from operating activities, adjusted for cash flows
related to the purchase and sale of property, plant, equipment and
intangible assets, cash flows related to leased assets, cash flows
related to one-off and adjusting items, and dividends received from
associates. These items are considered by management to be
non-discretionary, as continued investment in these assets is
required to support the day-to-day operations of the business. Free
Cash Flow is used by management for incentive purposes and is a
measure shared with and used by investors.
A reconciliation of net cash flows
from operating activities in the Consolidated Cash Flow Statement
to Free Cash Flow is provided in the table
below.
|
2024
£m
|
2023
£m
|
Net cash flows
from operating activities
|
678
|
737
|
Purchase of property, plant and
equipment
|
(171)
|
(167)
|
Purchase of intangible
assets
|
(44)
|
(44)
|
Capital element of lease payments
and initial direct costs incurred
|
(145)
|
(151)
|
Proceeds from sale of property,
plant, equipment and software
|
4
|
14
|
Cash impact of one-off and
adjusting items
|
77
|
107
|
Dividends received from
associates
|
11
|
4
|
Free Cash
Flow
|
410
|
500
|
Adjusted Free
Cash Flow and Adjusted Free Cash Flow
Conversion
Adjusted Free Cash Flow Conversion
is provided to demonstrate to investors the proportion of Adjusted
Profit After Tax that is converted to cash. It is calculated by
dividing Adjusted Free Cash Flow by Adjusted Profit After Tax,
expressed as a percentage. Adjusted Free Cash Flow is measured as
Free Cash Flow adjusted for product development additions and net
investment hedge cash interest through other comprehensive income.
Product development additions are adjusted due to their variable
size and non-underlying nature. Net investment hedge cash interest
through other comprehensive income is adjusted because the cash
relates to an item that is not recognised in Adjusted Profit After
Tax.
|
2024
£m
|
2023
£m
|
Free Cash Flow
|
410
|
500
|
Product development
additions
|
9
|
10
|
Net investment hedge cash interest
through Other Comprehensive Income
|
10
|
12
|
Adjusted Free
Cash Flow (a)
|
429
|
522
|
Adjusted Profit
After Tax (b)
|
536
|
584
|
Adjusted Free
Cash Flow Conversion (a/b)
|
80.0%
|
89.4%
|
The nearest IFRS-based equivalent
measure to Adjusted Free Cash Flow Conversion would be Cash
Conversion, which is shown in the table below to provide a
comparison in the calculation. Cash Conversion is calculated as net
cash flows from operating activities divided by profit attributable
to equity holders of the Company, expressed as a percentage.
Management considers that this is useful information for investors
as it gives an indication of the quality of profits, and ability of
the Group to turn profits into cash flows.
|
2024
£m
|
2023
£m
|
Net cash flows from operating
activities (a)
|
678
|
737
|
Profit attributable to equity
holders of the Company (b)
|
307
|
381
|
Cash Conversion
(a/b)
|
221.0%
|
193.4%
|
Adjusted Effective Tax Rate (Adjusted
ETR)
Adjusted Effective Tax Rate is used
to show investors and management the rate of tax applied to the
Group’s Adjusted Profit Before Tax. The measure is calculated
by dividing Adjusted Income Tax Expense by Adjusted Profit Before
Tax, expressed as a percentage.
|
2024
£m
|
2023
£m
|
Income tax
expense
|
98
|
112
|
Tax adjustments
on:
|
|
|
Amortisation and impairment of
intangible assets1
|
43
|
44
|
Net interest
adjustments
|
3
|
2
|
One-off and adjusting
items
|
23
|
24
|
Adjusted Income
Tax Expense (a)
|
167
|
182
|
Adjusted Profit
Before Tax (b)
|
703
|
766
|
Adjusted
Effective Tax Rate (a/b)
|
23.8%
|
23.8%
|
1.
Excluding computer software.
The Group’s effective tax
rate (ETR) for 2024 on reported profit before tax was 24.2% (2023:
22.7%). The Group’s Adjusted ETR before amortisation of
intangible assets (excluding computer software), one-off and
adjusting items, and the net interest adjustments for 2024 was
23.8% (2023: 23.8%). This compares with a blended rate of tax for
the countries in which the Group operates of 25.3% (2023: 25.1%).
The Group’s low tax rate in 2024 is primarily attributable to
the recognition of deferred tax on losses of £9m (2023:
£3m).
The Group’s tax charge and
Adjusted ETR will be influenced by the global mix and level of
profits, changes in future tax rates and other tax legislation,
foreign exchange rates, the utilisation of brought-forward tax
losses on which no deferred tax asset has been recognised, the
resolution of open issues with various tax authorities,
acquisitions and disposals.
Consolidated
Statement of Profit or Loss and Other Comprehensive
Income
For the year ended 31
December
|
Notes
|
2024
£m
|
2023
£m
|
2022
£m
|
Revenue
|
2
|
5,436
|
5,375
|
3,714
|
Operating
expenses
|
|
(4,831)
|
(4,711)
|
(3,373)
|
Net impairment losses on financial
assets
|
|
(56)
|
(39)
|
(24)
|
Operating
profit
|
|
549
|
625
|
317
|
Finance income
|
4
|
46
|
48
|
49
|
Finance cost
|
3
|
(197)
|
(189)
|
(79)
|
Share of profit from associates net
of tax
|
|
7
|
9
|
9
|
Profit before
income tax
|
|
405
|
493
|
296
|
Income tax
expense
|
5
|
(98)
|
(112)
|
(64)
|
Profit for the
year
|
|
307
|
381
|
232
|
Profit for the
year attributable to:
|
|
|
|
|
Equity holders of the
Company
|
|
307
|
381
|
232
|
Non-controlling
interests
|
|
–
|
–
|
–
|
Other
comprehensive income:
|
|
|
|
|
Items that are
not reclassified subsequently to the income
statement:
|
|
|
|
|
Remeasurement of net defined
benefit liability
|
|
–
|
–
|
2
|
|
|
|
|
|
Items that may
be reclassified subsequently to the income
statement:
|
|
|
|
|
Net exchange adjustments offset in
reserves
|
|
46
|
(352)
|
(232)
|
Net (loss)/gain on net investment
hedge
|
|
(17)
|
109
|
(68)
|
Effective portion of changes in
fair value of cash flow hedge
|
|
27
|
3
|
(6)
|
Cost of hedging
|
|
(5)
|
9
|
(2)
|
Tax related to items taken to other
comprehensive income
|
|
(6)
|
6
|
11
|
Other
comprehensive income for the year
|
|
45
|
(225)
|
(295)
|
Total
comprehensive income for the year
|
|
352
|
156
|
(63)
|
Total
comprehensive income for the year attributable
to:
|
|
|
|
|
Equity holders of the
Company
|
|
352
|
156
|
(63)
|
Non-controlling
interests
|
|
–
|
–
|
–
|
All profit is from continuing
operations.
Consolidated Balance
Sheet
At 31
December
|
Notes
|
2024
£m
|
2023
£m
|
Assets
|
|
|
|
Non-current
assets
|
|
|
|
Intangible
assets
|
9
|
7,108
|
7,042
|
Property, plant and
equipment
|
10
|
502
|
499
|
Right-of-use
assets
|
|
461
|
452
|
Investments in associated
undertakings
|
|
37
|
44
|
Other
investments
|
|
21
|
21
|
Deferred tax
assets
|
|
34
|
43
|
Contract costs
|
|
238
|
224
|
Retirement benefit
assets
|
|
3
|
3
|
Trade and other
receivables
|
|
57
|
45
|
Derivative financial
instruments
|
|
6
|
57
|
|
|
8,467
|
8,430
|
Current
assets
|
|
|
|
Other
investments
|
|
2
|
1
|
Inventories
|
|
229
|
207
|
Trade and other
receivables
|
|
909
|
880
|
Current tax
assets
|
|
22
|
33
|
Derivative financial
instruments
|
|
–
|
14
|
Cash and cash
equivalents
|
11
|
925
|
1,562
|
|
|
2,087
|
2,697
|
Liabilities
|
|
|
|
Current
liabilities
|
|
|
|
Trade and other
payables
|
|
(1,118)
|
(1,144)
|
Current tax
liabilities
|
|
(43)
|
(48)
|
Provisions for liabilities and
charges
|
17
|
(115)
|
(94)
|
Bank and other short-term
borrowings
|
|
(1,166)
|
(1,134)
|
Lease
liabilities
|
|
(130)
|
(127)
|
Derivative financial
instruments
|
|
(3)
|
(32)
|
|
|
(2,575)
|
(2,579)
|
Net current
(liabilities)/assets
|
|
(488)
|
118
|
Non-current
liabilities
|
|
|
|
Other payables
|
|
(69)
|
(71)
|
Bank and other long-term
borrowings
|
|
(2,498)
|
(3,153)
|
Lease
liabilities
|
|
(315)
|
(318)
|
Deferred tax
liabilities
|
|
(511)
|
(517)
|
Retirement benefit
obligations
|
16
|
(25)
|
(28)
|
Provisions for liabilities and
charges
|
17
|
(304)
|
(357)
|
Derivative financial
instruments
|
|
(29)
|
(16)
|
|
|
(3,751)
|
(4,460)
|
Net
assets
|
|
4,228
|
4,088
|
Equity
|
|
|
|
Capital and
reserves attributable to the Company’s equity
holders
|
|
|
|
Share capital
|
18
|
25
|
25
|
Share premium
|
|
15
|
14
|
Other reserves
|
|
583
|
532
|
Retained
earnings
|
|
3,606
|
3,518
|
|
|
4,229
|
4,089
|
Non-controlling
interests
|
|
(1)
|
(1)
|
Total
equity
|
|
4,228
|
4,088
|
Consolidated Statement of Changes in
Equity
For the year ended
31 December
|
Attributable to equity holders of
the Company
|
|
|
|
Share
capital
£m
|
Share
premium
£m
|
Other
reserves
£m
|
Retained
earnings
£m
|
Non-
controlling
interests
£m
|
Totale
quity
£m
|
At 1 January
2022
|
19
|
7
|
(1,927)
|
3,166
|
(1)
|
1,264
|
Profit for the
year
|
–
|
–
|
–
|
232
|
–
|
232
|
Other
comprehensive income:
|
|
|
|
|
|
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
(232)
|
–
|
–
|
(232)
|
Net loss on net investment
hedge
|
–
|
–
|
(68)
|
–
|
–
|
(68)
|
Net loss on cash flow
hedge1
|
–
|
–
|
(6)
|
–
|
–
|
(6)
|
Cost of hedging
|
–
|
–
|
(2)
|
–
|
–
|
(2)
|
Remeasurement of net defined
benefit liability
|
–
|
–
|
–
|
2
|
–
|
2
|
Tax related to items taken directly
to other comprehensive income
|
–
|
–
|
–
|
11
|
–
|
11
|
Total other comprehensive income
for the year
|
–
|
–
|
(308)
|
245
|
–
|
(63)
|
Transactions
with owners:
|
|
|
|
|
|
|
Shares
issued in the year
|
6
|
–
|
–
|
–
|
–
|
6
|
Merger relief on acquisition of
Terminix Global Holdings, Inc.
|
–
|
–
|
3,014
|
–
|
–
|
3,014
|
Gain on stock
options
|
–
|
2
|
–
|
–
|
–
|
2
|
Cost of issuing new
shares
|
–
|
–
|
(16)
|
–
|
–
|
(16)
|
Dividends paid to equity
shareholders
|
–
|
–
|
–
|
(122)
|
–
|
(122)
|
Cost of equity-settled share-based
payment plans
|
–
|
–
|
–
|
18
|
–
|
18
|
Tax related to items taken directly
to equity
|
–
|
–
|
–
|
(2)
|
–
|
(2)
|
Movement in the carrying value of
put options
|
–
|
–
|
–
|
(3)
|
–
|
(3)
|
At 31 December
2022
|
25
|
9
|
763
|
3,302
|
(1)
|
4,098
|
Adjustment on initial application
of IFRS 17
|
–
|
–
|
–
|
(1)
|
–
|
(1)
|
Adjusted balance as at 1 January
2023
|
25
|
9
|
763
|
3,301
|
(1)
|
4,097
|
Profit for the
year
|
–
|
–
|
–
|
381
|
–
|
381
|
Other
comprehensive income:
|
|
|
|
|
|
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
(352)
|
–
|
–
|
(352)
|
Net gain on net investment
hedge
|
–
|
–
|
109
|
–
|
–
|
109
|
Net gain on cash flow
hedge1
|
–
|
–
|
3
|
–
|
–
|
3
|
Cost of hedging
|
–
|
–
|
9
|
–
|
–
|
9
|
Tax related to items taken directly
to other comprehensive income
|
–
|
–
|
–
|
6
|
–
|
6
|
Total other comprehensive income
for the year
|
–
|
–
|
(231)
|
387
|
–
|
156
|
Transactions
with owners:
|
|
|
|
|
|
|
Gain on stock
options
|
–
|
5
|
–
|
–
|
–
|
5
|
Dividends paid to equity
shareholders
|
–
|
–
|
–
|
(201)
|
–
|
(201)
|
Cost of equity-settled share-based
payment plans
|
–
|
–
|
–
|
27
|
–
|
27
|
Movement in the carrying value of
put options
|
–
|
–
|
–
|
4
|
–
|
4
|
At 31 December
2023
|
25
|
14
|
532
|
3,518
|
(1)
|
4,088
|
Profit for the
year
|
–
|
–
|
–
|
307
|
–
|
307
|
Other
comprehensive income:
|
|
|
|
|
|
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
46
|
–
|
–
|
46
|
Net loss on net investment
hedge
|
–
|
–
|
(17)
|
–
|
–
|
(17)
|
Net gain on cash flow
hedge1
|
–
|
–
|
27
|
–
|
–
|
27
|
Cost of hedging
|
–
|
–
|
(5)
|
–
|
–
|
(5)
|
Tax related to items taken directly
to other comprehensive income
|
–
|
–
|
–
|
(6)
|
–
|
(6)
|
Total other comprehensive income
for the year
|
–
|
–
|
51
|
301
|
–
|
352
|
Transactions
with owners:
|
|
|
|
|
|
|
Gain on stock
options
|
–
|
1
|
–
|
–
|
–
|
1
|
Dividends paid to equity
shareholders
|
–
|
–
|
–
|
(229)
|
–
|
(229)
|
Cost of equity-settled share-based
payment plans
|
–
|
–
|
–
|
20
|
–
|
20
|
Tax related to items taken directly
to equity
|
–
|
–
|
–
|
(3)
|
–
|
(3)
|
Movement in the carrying value of
put options
|
–
|
–
|
–
|
(1)
|
–
|
(1)
|
At 31 December
2024
|
25
|
15
|
583
|
3,606
|
(1)
|
4,228
|
1.
£27m net gain (2023: £3m net gain; 2022: £6m net
loss) on cash flow hedge includes a £51m loss (2023: £28m
loss; 2022: £137m gain) from the effective portion of changes
in fair value, offset by reclassification to the cost of
acquisition of £nil (2023: £nil; 2022: £118m loss)
and a £78m gain (2023: £31m gain; 2022: £25m loss)
reclassification to the income statement due to changes in foreign
exchange rates.
Shares of £nil (2023:
£nil; 2022: £nil) have been netted against retained
earnings. This represents 11.4m (2023: 13.0m; 2022: 19.6m) shares
held by the Rentokil Initial Employee Share Trust, which is not
consolidated. The market value of these shares at 31 December 2024
was £45m (2023: £57m; 2022: £100m). Dividend income
from, and voting rights on, the shares held by the Trust have been
waived.
Analysis of other
reserves
|
Capital
reduction
reserve
£m
|
Merger
relief
reserve
£m
|
Cash
flow
hedge
reserve
£m
|
Translation
reserve
£m
|
Cost
of
hedging
£m
|
Total
£m
|
At 1 January
2022
|
(1,723)
|
–
|
9
|
(211)
|
(2)
|
(1,927)
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
–
|
(232)
|
–
|
(232)
|
Net loss on net investment
hedge
|
–
|
–
|
–
|
(68)
|
–
|
(68)
|
Net loss on cash flow
hedge1
|
–
|
–
|
(6)
|
–
|
–
|
(6)
|
Cost of hedging
|
–
|
–
|
–
|
–
|
(2)
|
(2)
|
Total comprehensive income for the
year
|
–
|
–
|
(6)
|
(300)
|
(2)
|
(308)
|
Transactions
with owners:
|
|
|
|
|
|
|
Merger relief on acquisition of
Terminix Global Holdings, Inc.
|
–
|
3,014
|
–
|
–
|
–
|
3,014
|
Cost of issuing new
shares
|
–
|
(16)
|
–
|
–
|
–
|
(16)
|
At 31 December
2022
|
(1,723)
|
2,998
|
3
|
(511)
|
(4)
|
763
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
–
|
(352)
|
–
|
(352)
|
Net gain on net investment
hedge
|
–
|
–
|
–
|
109
|
–
|
109
|
Net gain on cash flow
hedge1
|
–
|
–
|
3
|
–
|
–
|
3
|
Cost of hedging
|
–
|
–
|
–
|
–
|
9
|
9
|
Total comprehensive income for the
year
|
–
|
–
|
3
|
(243)
|
9
|
(231)
|
At 31 December
2023
|
(1,723)
|
2,998
|
6
|
(754)
|
5
|
532
|
Net exchange adjustments offset in
reserves
|
–
|
–
|
–
|
46
|
–
|
46
|
Net loss on net investment
hedge
|
–
|
–
|
–
|
(17)
|
–
|
(17)
|
Net gain on cash flow
hedge1
|
–
|
–
|
27
|
–
|
–
|
27
|
Cost of hedging
|
–
|
–
|
–
|
–
|
(5)
|
(5)
|
Total comprehensive income for the
year
|
–
|
–
|
27
|
29
|
(5)
|
51
|
At 31 December
2024
|
(1,723)
|
2,998
|
33
|
(725)
|
–
|
583
|
1.
£27m net gain (2023: £3m net gain; 2022: £6m net
loss) on cash flow hedge includes a £51m loss (2023: £28m
loss; 2022: £137m gain) from the effective portion of changes
in fair value, offset by reclassification to the cost of
acquisition of £nil (2023: £nil; 2022: £118m loss)
and a £78m gain (2023: £31m gain; 2022: £25m loss)
reclassification to the income statement due to changes in foreign
exchange rates.
The capital reduction reserve arose
in 2005 as a result of the scheme of arrangement of Rentokil
Initial 1927 plc, under section 425 of the Companies Act 1985, to
introduce a new holding company, Rentokil Initial plc, and the
subsequent reduction in capital approved by the High Court whereby
the nominal value of each ordinary share was reduced from 100p to
1p.
The excess of the fair value of
shares issued to fund the acquisition of Terminix over their par
value gave rise to a new reserve called a Merger Relief Reserve.
Under section 612 of the Companies Act 2006, merger relief is
available if certain circumstances are met when a business is
acquired by issuing shares to replace already issued shares. This
reserve is unrealised (and therefore not distributable), but it may
become realised at a later date, for example on disposal of the
investment to which it relates or on impairment of that investment
(which may occur after payment of a dividend by the
investment).
Consolidated Cash Flow
Statement
For the year ended 31
December
|
Notes
|
2024
£m
|
2023
£m
|
2022£
m
|
Cash flows from
operating activities
|
|
|
|
|
Operating
profit
|
|
549
|
625
|
317
|
Adjustments
for:
|
|
|
|
|
– Depreciation and impairment
of property, plant and equipment
|
|
159
|
154
|
148
|
– Depreciation and impairment
of leased assets
|
|
123
|
120
|
106
|
– Amortisation and impairment
of intangible assets (excluding computer
software)
|
|
199
|
175
|
118
|
– Amortisation and impairment
of computer software
|
|
26
|
26
|
22
|
– Other non-cash
items
|
|
18
|
26
|
8
|
Changes in working capital
(excluding the effects of acquisitions and exchange differences on
consolidation):
|
|
|
|
|
–
Inventories
|
|
(12)
|
(15)
|
(4)
|
– Contract
costs
|
|
(14)
|
(19)
|
(10)
|
– Trade and other
receivables
|
|
(38)
|
(29)
|
5
|
– Trade and other payables
and provisions
|
|
(101)
|
(60)
|
6
|
Interest
received
|
|
36
|
25
|
13
|
Interest paid1
|
|
(180)
|
(191)
|
(52)
|
Income tax paid
|
|
(87)
|
(100)
|
(77)
|
Net cash flows from operating
activities
|
|
678
|
737
|
600
|
Cash flows from
investing activities
|
|
|
|
|
Purchase of property, plant and
equipment
|
|
(171)
|
(167)
|
(153)
|
Purchase of intangible fixed
assets
|
|
(44)
|
(44)
|
(37)
|
Proceeds from sale of property,
plant and equipment
|
|
4
|
14
|
5
|
Acquisition of companies and
businesses, net of cash acquired
|
8
|
(172)
|
(242)
|
(1,018)
|
Disposal of companies and
businesses
|
|
–
|
–
|
1
|
Disposal of investment in
associate
|
|
–
|
19
|
–
|
Dividends received from
associates
|
|
11
|
4
|
4
|
Net change to cash flow from
investment in term deposits
|
|
(1)
|
–
|
1
|
Net cash flows from investing
activities
|
|
(373)
|
(416)
|
(1,197)
|
Cash flows from
financing activities
|
|
|
|
|
Dividends paid to equity
shareholders
|
7
|
(229)
|
(201)
|
(122)
|
Capital element of lease
payments
|
|
(145)
|
(157)
|
(104)
|
Cost of issuing new
shares
|
|
–
|
–
|
(16)
|
Cash outflow on settlement of
debt-related foreign exchange forward contracts
|
|
(9)
|
(3)
|
26
|
Proceeds from new
debt
|
|
–
|
–
|
2,383
|
Debt repayments
|
|
(369)
|
–
|
(844)
|
Net cash flows from financing
activities
|
|
(752)
|
(361)
|
1,323
|
Net (decrease)/increase in cash and
cash equivalents
|
|
(447)
|
(40)
|
726
|
Cash and cash equivalents at
beginning of year
|
|
832
|
879
|
242
|
Exchange loss on cash and cash
equivalents
|
|
(13)
|
(7)
|
(89)
|
Cash and cash
equivalents at end of the financial year
|
11
|
372
|
832
|
879
|
1.
Interest paid includes the interest element of lease payments of
£24m (2023: £25m; 2022: £10m).
Notes to the financial
statements
1. Changes in
accounting policies
Except as described below, the
accounting policies applied in these Consolidated Financial
Statements are the same as those applied in the Group’s
Consolidated Financial Statements for the year ended 31 December
2023.
The Group has adopted the following
new standards and amendments to standards, including any
consequential amendments to other standards, with effect from 1
January 2024:
●
|
amendments to IAS 1 –
Classification of liabilities as current or non-current and
non-current liabilities with covenants;
|
●
|
amendments to IFRS 16 – Lease
liability in sale and leaseback; and
|
●
|
amendments to IAS 7 and IFRS 7
– Supplier finance arrangements.
|
The application of these amendments
has had no material impact on the disclosures of the amounts
recognised in the Group’s Consolidated Financial Statements.
Consequently, no adjustment has been made to the comparative
financial information at 31 December 2023.
New standards
and interpretations not yet adopted
Certain new accounting standards
and interpretations have been published that are not mandatory for
31 December 2024 reporting periods, and have not been adopted early
by the Group.
●
|
IFRS 18 – Presentation and
disclosure in financial statements
|
IFRS 18 is effective for annual
periods beginning on or after 1 January 2027 and will replace IAS 1
– Presentation of financial statements. It will introduce new
requirements that are intended to help to achieve comparability of
the financial performance of similar entities, and provide more
relevant information and transparency to users. Even though IFRS 18
will not impact the recognition or measurement of items in the
financial statements, its impacts on presentation and disclosure
are expected to be pervasive; in particular those related to the
statement of comprehensive income or loss, and providing
management-defined performance measures within the financial
statements.
Management is currently assessing
the detailed implications of applying the new standard on the
Group’s consolidated financial
statements.
2. Revenue
recognition and operating segments
Revenue
recognition
Revenue represents the transfer of
promised goods or services to customers in an amount that reflects
the consideration to which the Group expects to be entitled. All
revenue is considered revenue from contracts with customers as
defined by IFRS 15, including job work and sales of goods. Under
IFRS 15, revenue is recognised when a customer obtains control of
goods or services in line with identifiable performance
obligations. In the majority of cases the Group considers that the
contracts it enters into are contracts for bundled services which
are accounted for as a single performance obligation. Accordingly
the majority of revenue across the Group is recognised on an output
basis evenly over the course of the contract because the customer
simultaneously receives and consumes the benefits provided by the
Group’s performance as it performs. Job work is short-term
contract revenue whereby the period of service is typically less
than one month in duration. The performance obligations linked to
this revenue type are individual to each job due to their nature,
with revenue being recognised at a point in time on completion.
Where consumables are supplied separately from the service
contract, revenue is recognised at the point the goods
transfer.
The transaction price reported for
all contracts is the price agreed in the contract and there are no
material elements of variable consideration, financing component or
non-cash consideration. The Group applies the practical expedient
in paragraph 121 of IFRS 15 and does not disclose information about
remaining performance obligations because the Group has a right to
consideration from customers in an amount that corresponds directly
with the value to the customer of the performance obligations
completed to date.
Disaggregation of revenue into
category, region and major type of revenue stream is shown below
under segmental reporting.
Contract
costs
Contract costs are mainly
incremental costs of obtaining contracts (primarily sales
commissions directly related to contracts obtained), and to a
lesser extent costs to fulfil contracts which are not within the
scope of other standards (mainly incremental costs of putting
resources in place to fulfil contracts).
It is anticipated that these costs
are recoverable over the life of the contract to which they relate.
Accordingly, the Group capitalises them as contract costs and
amortises them over the expected life of the contracts. Management
takes a portfolio approach to recognising contract costs, and the
expected length of contracts across the Group and associated
amortisation periods are between three and seven
years.
The contract costs recognised in
the balance sheet at the period end amounted to £238m (2023:
£224m; 2022: £215m). The amount of amortisation
recognised in the period was £92m (2023: £121m; 2022:
£39m) and impairment losses were £nil (2023: £nil;
2022: £nil).
Applying the practical expedient in
paragraph 94 of IFRS 15, the Group recognises the incremental costs
of obtaining contracts as an expense when incurred if the
amortisation period of the assets that the Group otherwise would
have recognised is one year or less.
Contract
liabilities
Contract liabilities relate to
advance consideration received from customers where the performance
obligations have yet to be satisfied. All opening balances have
subsequently been satisfied in the year. In most business
categories where revenue is recognised over time, customers are
invoiced in advance or simultaneously with performance obligations
being satisfied.
Segment
reporting
Segmental information has been
presented in accordance with IFRS 8 Operating Segments. The
Group’s operating segments are regions and this reflects the
internal management reporting structures and the way information is
reviewed by the chief operating decision maker (the Chief
Executive). Each region is headed by a Regional Managing Director
who reports directly to the Chief Executive and is a member of the
Group’s Executive Leadership Team responsible for the review
of Group performance. The businesses within each operating segment
operate in a number of different countries and sell services across
three business segments.
The LATAM region is combined with
Europe in the Group’s segment reporting. It is the
Group’s smallest region and not considered reportable under
the quantitative thresholds in IFRS 8. It is combined with Europe
as they are similar with respect to economic characteristics, the
nature of services provided, the type of customers, methods used to
provide services, and language and cultural
similarities.
Management and the Board also
reviews regional data summarised into North America and
International, and these sub-totals are reflected in the relevant
Notes to the Consolidated Financial Statements.
Disaggregated revenue under IFRS 15
is the same as the segmental analysis below. Restructuring costs,
one-off and adjusting items, amortisation and impairment of
intangible assets (excluding computer software), and central and
regional costs are presented at a Group level as they are not
targeted or managed at reportable segment level. The basis of
presentation is consistent with the information reviewed by
internal management.
Revenue and profit from continuing
operations
|
Revenue
2024
£m
|
Revenue
2023
£m
|
Revenue
2022
£m
|
Operating
profit
2024
£m
|
Operating
profit
2023
£m
|
Operating
profit
2022
£m
|
North
America1
|
|
|
|
|
|
|
Pest Control
|
3,152
|
3,201
|
1,746
|
539
|
599
|
297
|
Hygiene &
Wellbeing
|
108
|
105
|
103
|
19
|
18
|
18
|
Sub-total North
America
|
3,260
|
3,306
|
1,849
|
558
|
617
|
315
|
|
|
|
|
|
|
|
International
|
|
|
|
|
|
|
Europe (incl.
LATAM)
|
|
|
|
|
|
|
Pest Control
|
531
|
516
|
427
|
124
|
124
|
103
|
Hygiene &
Wellbeing
|
353
|
344
|
322
|
54
|
52
|
53
|
France Workwear
|
230
|
221
|
192
|
41
|
39
|
31
|
|
1,114
|
1,081
|
941
|
219
|
215
|
187
|
UK &
Sub-Saharan Africa
|
|
|
|
|
|
|
Pest Control
|
205
|
195
|
182
|
53
|
51
|
47
|
Hygiene &
Wellbeing
|
230
|
195
|
183
|
47
|
43
|
48
|
|
435
|
390
|
365
|
100
|
94
|
95
|
Asia &
MENAT
|
|
|
|
|
|
|
Pest Control
|
265
|
250
|
231
|
35
|
34
|
34
|
Hygiene &
Wellbeing
|
89
|
89
|
90
|
11
|
11
|
11
|
|
354
|
339
|
321
|
46
|
45
|
45
|
Pacific
|
|
|
|
|
|
|
Pest Control
|
134
|
124
|
104
|
22
|
22
|
16
|
Hygiene &
Wellbeing
|
128
|
125
|
123
|
33
|
33
|
32
|
|
262
|
249
|
227
|
55
|
55
|
48
|
|
|
|
|
|
|
|
Sub-total
International
|
2,165
|
2,059
|
1,854
|
420
|
409
|
375
|
|
|
|
|
|
|
|
Total
|
5,425
|
5,365
|
3,703
|
978
|
1,026
|
690
|
|
|
|
|
|
|
|
Central and
regional overheads2
|
11
|
10
|
11
|
(137)
|
(121)
|
(107)
|
Restructuring
costs
|
–
|
–
|
–
|
(7)
|
(7)
|
(12)
|
Revenue and
Adjusted Operating Profit
|
5,436
|
5,375
|
3,714
|
834
|
898
|
571
|
One-off and adjusting
items
|
|
|
|
(86)
|
(98)
|
(136)
|
Amortisation and impairment of
intangible assets3
|
|
|
|
(199)
|
(175)
|
(118)
|
Operating
profit
|
|
|
|
549
|
625
|
317
|
Finance
income
|
|
|
|
46
|
48
|
49
|
Finance
cost
|
|
|
|
(197)
|
(189)
|
(79)
|
Share of profit
from associates net of tax
|
|
|
|
7
|
9
|
9
|
Profit before
income tax
|
|
|
|
405
|
493
|
296
|
1.
During 2024, there were impairment losses recognised in North
America related to ROU assets of £nil (2023: £nil; 2022:
£17m) and related to property, plant and equipment of
£nil (2023: £nil; 2022: £8m).
2. Central and regional overheads
revenue relates to the wholesale of metalwork and consumables,
including hygiene and pest control products. It is managed
centrally rather than in any region.
3. Excluding computer software
which is included in the segment operating profit
measure.
Other
segment items included in the consolidated income statement are as
follows:
|
Amortisation
and
impairment
of
intangibles1
2024
£m
|
Amortisation
and
impairment
of
intangibles1
2023
£m
|
Amortisation
andimpairment
of
intangibles1
2022
£m
|
North
America
|
114
|
118
|
59
|
International
|
|
|
|
Europe (incl.
LATAM)
|
39
|
24
|
29
|
UK & Sub-Saharan
Africa
|
6
|
8
|
–
|
Asia &
MENAT
|
22
|
11
|
20
|
Pacific
|
8
|
6
|
4
|
Sub-total
International
|
75
|
49
|
53
|
Central and
regional
|
10
|
8
|
6
|
Total
|
199
|
175
|
118
|
Tax effect
|
(43)
|
(44)
|
(25)
|
Total after tax
effect
|
156
|
131
|
93
|
1.
Excluding computer software.
3. Finance cost
|
2024
£m
|
2023
£m
|
2022
£m
|
Hedged interest payable on
medium-term notes issued1
|
61
|
61
|
39
|
Interest payable on bank loans and
overdrafts1
|
51
|
42
|
5
|
Interest payable on RCF1
|
1
|
3
|
1
|
Interest payable on foreign
exchange swaps2
|
44
|
44
|
19
|
Interest payable on
leases
|
24
|
25
|
10
|
Amortisation of discount on
provisions
|
11
|
14
|
3
|
Foreign exchange loss on
translation of foreign assets/liabilities
|
5
|
–
|
–
|
Fair value loss on hedge
ineffectiveness
|
–
|
–
|
2
|
Total finance
cost
|
197
|
189
|
79
|
1.
Interest expense on financial liabilities held at amortised
cost.
2.
Interest payable on foreign exchange swaps including coupon
interest payable for the year was £54m (2023: £55m).
£10m has been reported in other comprehensive income due to
hedge accounting (2023:
£12m).
4. Finance income
|
2024
£m
|
2023
£m
|
2022
£m
|
Bank interest
received
|
36
|
25
|
5
|
Fair value gain on hedge
ineffectiveness
|
3
|
1
|
22
|
Foreign exchange gain on
translation of foreign assets/liabilities
|
–
|
11
|
–
|
Hyperinflation accounting
adjustment
|
7
|
11
|
22
|
Total finance
income
|
46
|
48
|
49
|
5. Income tax expense
Analysis of charge in the
year:
|
2024
£m
|
2023
£m
|
2022
£m
|
Current tax
expense
|
89
|
94
|
76
|
Adjustment in respect of previous
periods
|
5
|
(8)
|
2
|
Total current
tax
|
94
|
86
|
78
|
Deferred tax
expense/(credit)
|
11
|
30
|
(3)
|
Deferred tax adjustment in respect
of previous periods
|
(7)
|
(4)
|
(11)
|
Total deferred
tax
|
4
|
26
|
(14)
|
Total income tax
expense
|
98
|
112
|
64
|
The income tax expense for the
period comprises both current and deferred tax. Current tax expense
represents the amount payable on this year’s taxable profits
and any adjustment relating to prior years. Deferred tax is an
accounting adjustment to provide for tax that is expected to arise
in the future due to differences between accounting and tax bases.
Deferred tax is determined using tax rates that are expected to
apply when the timing difference reverses based on tax rates which
are enacted or substantively enacted at the balance sheet date. Tax
is recognised in the income statement, except to the extent that it
relates to items recognised in other comprehensive income or
equity. In this case the tax is also recognised in other
comprehensive income or equity as appropriate.
The current income tax charge is
calculated on the basis of the tax laws enacted or substantively
enacted at the balance sheet date in the countries where the
Group’s subsidiaries and associates operate and generate
taxable income.
Deferred income tax is provided on
temporary differences arising between the tax bases of assets and
liabilities and their carrying amounts in the Consolidated
Financial Statements. The following temporary differences are not
provided for: the initial recognition of goodwill; the initial
recognition of assets or liabilities in transactions other than a
business combination that at the time of the transactions affect
neither the accounting nor taxable profit or loss; and differences
relating to investments in subsidiaries to the extent that they
will probably not reverse in the foreseeable future. The amount of
deferred income tax is determined using tax rates (and laws) that
have been enacted (or substantively enacted) at the balance sheet
date, and are expected to apply when the related deferred income
tax asset is realised or the deferred income tax liability is
settled. Deferred tax balances are not
discounted.
Deferred tax assets and liabilities
are offset against each other when the timing differences relate to
income taxes levied by the same tax authority on an entity or
different entities which are part of a tax consolidation and there
would be the intention to settle on a net
basis.
Deferred income tax assets are
recognised to the extent that it is probable that future taxable
profits will be available against which the temporary differences
can be utilised. The amount of deferred tax assets recognised at
each balance sheet date is adjusted to reflect changes in
management’s assessment of future taxable profits that will
enable the tax losses to be recovered. In recognising the deferred
tax asset in respect of losses, management has estimated the
quantum of future taxable profits over the next ten years as this
is the period over which it is considered that profits can be
reasonably estimated.
A deferred tax asset of £41m
has been recognised in respect of losses which are expected to be
utilised within 10 years (2023: £38m), of which £30m
(2023: £28m) relates to UK losses carried forward at 31
December 2024. This amount has been calculated by estimating the
future UK taxable profits, against which the UK tax losses will be
utilised, progressively risk-weighted, and applying the tax rates
(substantively enacted as at the balance sheet date) applicable for
each year. A deferred tax asset is now recognised on all the UK tax
losses (2023: £34m unrecognised).
The estimates of future profits are
based on management’s financial forecasts which are used to
support other aspects of the financial statements, such as
impairment testing. At the balance sheet date the Group had tax
losses of £242m (2023: £169m) on which no deferred tax
asset is recognised because it is not considered probable that
future taxable profits will be available in certain jurisdictions
to be able to benefit from those tax losses. Of the losses,
£203m (2023: £95m) will expire at various dates between
2025 and 2045.
The cash tax paid for the year was
£87m (2023: £100m). The decrease was attributable to a
reduction of cash tax payments in line with Group profits and one
off tax repayments received in 2024. The cash tax paid is expected
to increase in future periods in line with Group
profits.
6. Earnings per share
Basic earnings per share is
calculated by dividing the profit after tax attributable to equity
holders of the Company by the weighted average number of shares in
issue during the year, excluding those held in the Rentokil Initial
Employee Share Trust (see note at the bottom of the Consolidated
Statement of Changes in Equity) which are treated as cancelled, and
including share options for which all conditions have been
met.
For diluted earnings per share, the
weighted average number of ordinary shares in issue is adjusted to
include all potential dilutive ordinary shares. The Group’s
potentially dilutive ordinary shares relate to the contingent
issuable shares under the Group’s long-term incentive plans
(LTIPs) to the extent that the performance conditions have been met
at the end of the period. These share options are issued for nil
consideration to employees if performance conditions are
met.
For the calculation of diluted
earnings per share, 435,578 share options were anti-dilutive and
not included in the calculation of the dilutive effect as at 31
December 2024 (2023: 18,422; 2022: 1,290,294).
Details of the calculation of
earnings per share are set out below:
|
2024
£m
|
2023
£m
|
2022
£m
|
Profit
attributable to equity holders of the Company
|
307
|
381
|
232
|
|
|
|
|
Weighted average
number of ordinary shares in issue (million)
|
2,521
|
2,516
|
2,002
|
Adjustment for potentially dilutive
shares (million)
|
7
|
11
|
12
|
Weighted average
number of ordinary shares for diluted earnings per share
(million)
|
2,528
|
2,527
|
2,014
|
|
|
|
|
Basic earnings per
share
|
12.17p
|
15.14p
|
11.57p
|
Diluted earnings per
share
|
12.14p
|
15.07p
|
11.51p
|
7. Dividends
Dividend distribution to the
Company’s shareholders is recognised as a liability in the
Group’s Financial Statements in the period in which the
dividends are approved by the Company’s shareholders. Interim
dividends are recognised when paid.
|
2024
£m
|
2023
£m
|
2022
£m
|
2021 final dividend paid –
4.30p per share
|
–
|
–
|
80
|
2022 interim dividend paid –
2.40p per share
|
–
|
–
|
42
|
2022 final dividend paid –
5.15p per share
|
–
|
131
|
–
|
2023 interim dividend paid –
2.75p per share
|
–
|
70
|
–
|
2023 final dividend paid –
5.93p per share
|
149
|
–
|
–
|
2024 interim dividend paid –
3.16p per share
|
80
|
–
|
–
|
|
229
|
201
|
122
|
An interim dividend of 3.16p per
share was paid on 16 September 2024 amounting to £80m. A final
dividend in respect of 2024 of 5.93p per share is to be proposed at
the Annual General Meeting on 7 May 2025.
The aggregate amount of the
proposed dividend to be paid out of retained earnings at 31
December 2024, but not recognised as a liability at year end, is
£150m (2023: £150m; 2022:
£130m).
8. Business
combinations
During the year the Group purchased
100% of the share capital or trade and assets of 36 companies and
businesses (2023: 41). The total consideration in respect of these
acquisitions was £182m (2023: £261m), and the cash
outflow from current and past period acquisitions net of cash
acquired was £172m (2023: £242m).
Goodwill on all acquisitions
represents the synergies and other benefits expected to be realised
from integrating acquired businesses into the Group, such as
improved route density, expansion in use of best-in-class digital
tools and back office synergies. Details of goodwill and the fair
value of net assets acquired in the year are as
follows:
|
2024
£m
|
2023
£m
|
Purchase
consideration
|
|
|
– Cash
paid
|
115
|
203
|
– Deferred and contingent
consideration
|
67
|
58
|
Total purchase
consideration
|
182
|
261
|
Fair value of net assets
acquired
|
(51)
|
(88)
|
Goodwill from
current-year acquisitions
|
131
|
173
|
Goodwill expected to be deductible
for tax purposes
|
84
|
76
|
Deferred consideration of £35m
and contingent consideration of £32m are payable in respect of
the above acquisitions (2023: £15m and £43m
respectively). Contingent consideration is payable based on a
variety of conditions, including revenue and profit targets being
met. Amounts for both deferred and contingent consideration are
payable over the next five years. The Group has recognised
contingent and deferred consideration based on fair value at the
acquisition date. A range of outcomes for contingent consideration
payments cannot be estimated due to the variety of performance
conditions and the volume of businesses the Group acquires. During
the year, there were releases of contingent consideration
liabilities not paid of £7m (2023:
£nil).
The fair values6 of assets and
liabilities arising from acquisitions in the year are as
follows:
|
2024
£m
|
2023
£m
|
Non-current
assets
|
|
|
– Intangible
assets1
|
56
|
80
|
– Property, plant and
equipment2
|
11
|
12
|
Current assets3
|
27
|
22
|
Current liabilities4
|
(23)
|
(12)
|
Non-current liabilities5
|
(20)
|
(14)
|
Net assets
acquired
|
51
|
88
|
1. Includes £46m (2023:
£69m) of customer lists and £10m (2023: £11m) of
other intangibles.
2. Includes £4m (2023:
£1m) of ROU assets.
3. Includes cash acquired of
£2m (2023: £8m), inventory of £11m (2023: £2m),
and trade and other receivables of £14m (2023:
£12m).
4. Includes trade and other
payables of £23m (2023: £10m).
5. Includes £9m of deferred
tax liabilities relating to acquired intangibles (2023: £12m),
lease liabilities of £4m (2023: £1m), and other
liabilities of £7m (2023: £1m).
6. The fair values of assets and
liabilities from acquisitions in the current year will be finalised
in the 2025 Financial Statements. These fair values are provisional
as the acquisition accounting has not yet been finalised, primarily
due to the proximity of many acquisitions to the year
end.
The
cash outflow from current and past acquisitions is as
follows:
|
2024
£m
|
2023
£m
|
Total purchase
consideration
|
182
|
261
|
Consideration payable in future
periods
|
(67)
|
(58)
|
Purchase consideration paid in
cash
|
115
|
203
|
Cash and cash equivalents in
acquired companies and businesses
|
(2)
|
(8)
|
Cash outflow on current period
acquisitions
|
113
|
195
|
Deferred and contingent
consideration paid
|
59
|
47
|
Cash outflow on
current and past acquisitions
|
172
|
242
|
From the dates of acquisition to 31
December 2024, new acquisitions contributed £68m to revenue
and £1m to operating profit (2023: £75m and £10m
respectively).
If the acquisitions had occurred on
1 January 2024, the revenue and operating profit of the combined
Group would have amounted to £5,492m and £551m
respectively (2023: £5,414m and £628m
respectively).
9. Intangible
assets
A breakdown of intangible assets is
as shown below:
|
Goodwill
£m
|
Customer
lists
£m
|
Indefinite-
lived
brands
£m
|
Other
intangibles
£m
|
Product
development
£m
|
Computer
software
£m
|
Total
£m
|
Cost
|
|
|
|
|
|
|
|
At 1 January
2023
|
5,165
|
1,473
|
1,185
|
81
|
55
|
206
|
8,165
|
Exchange
differences
|
(269)
|
(70)
|
(58)
|
(5)
|
–
|
(3)
|
(405)
|
Additions
|
–
|
–
|
–
|
–
|
10
|
34
|
44
|
Disposals/retirements
|
(2)
|
(15)
|
–
|
(12)
|
–
|
(8)
|
(37)
|
Acquisition of companies and
businesses
|
172
|
69
|
–
|
11
|
–
|
–
|
252
|
Hyperinflationary
adjustment
|
14
|
3
|
–
|
1
|
–
|
–
|
18
|
At 31 December
2023
|
5,080
|
1,460
|
1,127
|
76
|
65
|
229
|
8,037
|
At 1 January
2024
|
5,080
|
1,460
|
1,127
|
76
|
65
|
229
|
8,037
|
Exchange
differences
|
50
|
(13)
|
18
|
–
|
–
|
(1)
|
54
|
Additions
|
–
|
–
|
–
|
–
|
9
|
46
|
55
|
Disposals/retirements
|
–
|
(22)
|
–
|
(2)
|
–
|
(22)
|
(46)
|
Acquisition of companies and
businesses
|
113
|
37
|
–
|
10
|
–
|
–
|
160
|
Hyperinflationary
adjustment
|
10
|
4
|
–
|
1
|
–
|
–
|
15
|
At 31 December
2024
|
5,253
|
1,466
|
1,145
|
85
|
74
|
252
|
8,275
|
Accumulated
amortisation and impairment
|
|
|
|
|
|
|
|
At 1 January
2023
|
(65)
|
(573)
|
–
|
(44)
|
(37)
|
(143)
|
(862)
|
Exchange
differences
|
12
|
26
|
–
|
2
|
–
|
3
|
43
|
Disposals/retirements
|
2
|
15
|
–
|
12
|
–
|
7
|
36
|
Hyperinflationary
adjustment
|
(10)
|
(1)
|
–
|
–
|
–
|
–
|
(11)
|
Impairment
charge
|
(3)
|
(1)
|
–
|
–
|
–
|
–
|
(4)
|
Amortisation
charge
|
–
|
(155)
|
–
|
(9)
|
(7)
|
(26)
|
(197)
|
At 31 December
2023
|
(64)
|
(689)
|
–
|
(39)
|
(44)
|
(159)
|
(995)
|
At 1 January
2024
|
(64)
|
(689)
|
–
|
(39)
|
(44)
|
(159)
|
(995)
|
Exchange
differences
|
4
|
14
|
–
|
–
|
–
|
1
|
19
|
Disposals/retirements
|
–
|
22
|
–
|
2
|
–
|
20
|
44
|
Hyperinflationary
adjustment
|
(8)
|
(2)
|
–
|
–
|
–
|
–
|
(10)
|
Impairment
charge
|
(28)
|
–
|
–
|
–
|
(2)
|
–
|
(30)
|
Amortisation
charge
|
–
|
(152)
|
–
|
(9)
|
(8)
|
(26)
|
(195)
|
At 31 December
2024
|
(96)
|
(807)
|
–
|
(46)
|
(54)
|
(164)
|
(1,167)
|
Net book
value
|
|
|
|
|
|
|
|
At 1 January
2023
|
5,100
|
900
|
1,185
|
37
|
18
|
63
|
7,303
|
At 31 December
2023
|
5,016
|
771
|
1,127
|
37
|
21
|
70
|
7,042
|
At 31 December
2024
|
5,157
|
659
|
1,145
|
39
|
20
|
88
|
7,108
|
10. Property,
plant and equipment
A breakdown of property, plant and
equipment is shown below:
|
Land
and
buildings
£m
|
Service
contract
equipment
£m
|
Other
plant
and
equipment
£m
|
Vehicles
and
office
equipment
£m
|
Total
£m
|
Cost
|
|
|
|
|
|
At 1 January
2023
|
127
|
587
|
215
|
255
|
1,184
|
Exchange
differences
|
(7)
|
(20)
|
(5)
|
(15)
|
(47)
|
Additions
|
7
|
123
|
14
|
23
|
167
|
Disposals
|
(9)
|
(77)
|
(9)
|
(25)
|
(120)
|
Acquisition of companies and
businesses
|
–
|
1
|
1
|
8
|
10
|
Hyperinflationary
adjustment
|
4
|
–
|
–
|
1
|
5
|
Reclassification from IFRS 16 ROU
assets1
|
–
|
–
|
–
|
8
|
8
|
At 31 December
2023
|
122
|
614
|
216
|
255
|
1,207
|
At 1 January
2024
|
122
|
614
|
216
|
255
|
1,207
|
Exchange
differences
|
(3)
|
(31)
|
(8)
|
(5)
|
(47)
|
Additions
|
7
|
126
|
14
|
24
|
171
|
Disposals
|
(4)
|
(98)
|
(16)
|
(51)
|
(169)
|
Acquisition of companies and
businesses
|
1
|
1
|
–
|
5
|
7
|
Hyperinflationary
adjustment
|
1
|
–
|
–
|
1
|
2
|
Reclassification from IFRS 16 ROU
assets1
|
–
|
–
|
–
|
8
|
8
|
At 31 December
2024
|
124
|
612
|
206
|
237
|
1,179
|
Accumulated
depreciation and impairment
|
|
|
|
|
|
At 1 January
2023
|
(44)
|
(356)
|
(151)
|
(138)
|
(689)
|
Exchange
differences
|
2
|
14
|
5
|
7
|
28
|
Disposals
|
4
|
75
|
8
|
22
|
109
|
Hyperinflationary
adjustment
|
(1)
|
–
|
–
|
(1)
|
(2)
|
Depreciation
charge
|
(5)
|
(102)
|
(15)
|
(32)
|
(154)
|
At 31 December
2023
|
(44)
|
(369)
|
(153)
|
(142)
|
(708)
|
At 1 January
2024
|
(44)
|
(369)
|
(153)
|
(142)
|
(708)
|
Exchange
differences
|
(1)
|
20
|
7
|
3
|
29
|
Disposals
|
3
|
96
|
16
|
46
|
161
|
Depreciation
charge
|
(5)
|
(108)
|
(14)
|
(32)
|
(159)
|
At 31 December
2024
|
(47)
|
(361)
|
(144)
|
(125)
|
(677)
|
Net book
value
|
|
|
|
|
|
At 1 January 2023
|
83
|
231
|
64
|
117
|
495
|
At 31 December
2023
|
78
|
245
|
63
|
113
|
499
|
At 31 December
2024
|
77
|
251
|
62
|
112
|
502
|
1.
Certain leased assets become owned assets at the end of their lease
period and are therefore reclassified from ROU
assets.
11. Cash and
cash equivalents
Cash and cash equivalents include
cash in hand, short-term bank deposits and other short-term highly
liquid investments with original maturities of three months or less
(and subject to insignificant changes in value). In the cash flow
statement, cash and cash equivalents are shown net of bank
overdrafts. Bank overdrafts are shown within borrowings in current
liabilities on the balance sheet.
Cash at bank and in hand includes
£16m (2023: £15m) of restricted cash. This cash is held
in respect of specific contracts and can only be utilised in line
with terms under the contractual arrangements.
Cash at bank and in hand also
includes £71m (2023: £70m) of cash held in countries with
foreign exchange regulations. This cash is repatriated to the UK
where possible, if not required for operational purposes in
country.
Fair value is equal to carrying
value for all cash and cash equivalents.
|
Gross
amounts
2024
£m
|
Gross
amounts
2023
£m
|
Cash at bank and in
hand
|
796
|
1,080
|
Money market
funds
|
24
|
153
|
Short-term bank
deposits
|
105
|
329
|
Cash and cash
equivalents in the Consolidated Balance Sheet
|
925
|
1,562
|
Bank overdraft
|
(553)
|
(730)
|
Cash and cash
equivalents in the Consolidated Cash Flow
Statement
|
372
|
832
|
12.
Reconciliation of net changes in cash and cash equivalents to net
debt
Reconciliation of net change in
cash and cash equivalents to net debt:
|
Opening
2024£m
|
Cash
flows£m
|
Non-cash
(fair
value
changes,
accruals
and
acquisitions)
£m
|
Non-cash
(foreign
exchange,
additions
and
other)
£m
|
Closing
2024
£m
|
Bank and other short-term
borrowings
|
(1,134)
|
602
|
(99)
|
(535)
|
(1,166)
|
Bank and other long-term
borrowings
|
(3,153)
|
–
|
–
|
655
|
(2,498)
|
Lease
liabilities
|
(445)
|
169
|
(146)
|
(23)
|
(445)
|
Other
investments
|
1
|
1
|
–
|
–
|
2
|
Fair value of debt-related
derivatives
|
23
|
68
|
(7)
|
(110)
|
(26)
|
Gross
debt
|
(4,708)
|
840
|
(252)
|
(13)
|
(4,133)
|
Cash and cash equivalents in the
Consolidated Balance Sheet
|
1,562
|
(637)
|
–
|
–
|
925
|
Net
debt
|
(3,146)
|
203
|
(252)
|
(13)
|
(3,208)
|
|
Opening
2023
£m
|
Cash
flows
£m
|
Non-cash
(fair
valuechanges,
accruals and
acquisitions)
£m
|
Non-cash
(foreign
exchange,
additions
and other)
£m
|
Closing
2023
£m
|
Bank and other short-term
borrowings
|
(1,345)
|
664
|
(106)
|
(347)
|
(1,134)
|
Bank and other long-term
borrowings
|
(3,574)
|
–
|
–
|
421
|
(3,153)
|
Lease
liabilities
|
(460)
|
182
|
(162)
|
(5)
|
(445)
|
Other
investments
|
1
|
–
|
–
|
–
|
1
|
Fair value of debt-related
derivatives
|
(71)
|
39
|
(1)
|
56
|
23
|
Gross
debt
|
(5,449)
|
885
|
(269)
|
125
|
(4,708)
|
Cash and cash equivalents in the
Consolidated Balance Sheet
|
2,170
|
(601)
|
–
|
(7)
|
1,562
|
Net
debt
|
(3,279)
|
284
|
(269)
|
118
|
(3,146)
|
13. Fair value
estimation
All financial instruments held at
fair value are classified by reference to the source of inputs used
to derive the fair value. The following hierarchy is
used:
Level
1
|
– unadjusted quoted
prices in active markets for identical assets or
liabilities;
|
Level
2
|
– inputs other than quoted
prices that are observable for the asset or liability either
directly as prices or indirectly through modelling based on prices;
and
|
Level
3
|
– inputs for the asset or
liability that are not based on observable market
data.
|
Financial
instrument
|
Hierarchy
level
|
Valuation
method
|
Financial assets traded in active
markets
|
1
|
Current bid
price
|
Financial liabilities traded in
active markets
|
1
|
Current ask
price
|
Listed bonds
|
1
|
Quoted market
prices
|
Money market
funds
|
1
|
Quoted market
prices
|
Interest rate/currency
swaps
|
2
|
Discounted cash flow based on
market swap rates
|
Forward foreign exchange
contracts
|
2
|
Forward exchange market
rates
|
Borrowings not traded in active
markets (term loans and uncommitted facilities)
|
2
|
Nominal value
|
Money market
deposits
|
2
|
Nominal value
|
Trade payables and
receivables
|
2
|
Nominal value less estimated credit
adjustments
|
Contingent consideration (including
put option liability)
|
3
|
Discounted cash flow using
WACC
|
14. Analysis of
bank and bond debt
Borrowings are recognised initially
at fair value, net of transaction costs incurred. Borrowings are
classified as current liabilities unless the Group has a continuing
right to defer settlement of the liability for at least 12 months
after the balance sheet date.
The Group’s bank debt
comprises:
|
Facility
amount
2024
£m
|
Drawn
at
year
end
2024
£m
|
Headroom
2024
£m
|
Interest
rateat
year
end
2024%
|
Facility
amount
2023
£m
|
Drawn at
year end
2023
£m
|
Headroom
2023
£m
|
Interest rate
at year end
2023
%
|
Current
|
|
|
|
|
|
|
|
|
$700m term loan due October
2025
|
559
|
559
|
–
|
5.18
|
–
|
–
|
–
|
–
|
$50m term loan due May
2025
|
40
|
–
|
40
|
0.21
|
–
|
–
|
–
|
–
|
Non-current
|
|
|
|
|
|
|
|
|
$700m term loan due October
2025
|
–
|
–
|
–
|
–
|
550
|
550
|
–
|
5.94
|
$1.0bn RCF due October
2029
|
799
|
–
|
799
|
0.14
|
785
|
–
|
785
|
0.14
|
The RCF was undrawn throughout 2023
and 2024.
Medium-term notes and bond debt
comprises:
|
Bond
interest
coupon
2024
|
Effective
hedged
interest
rate
2024
|
Bond interest
coupon
2023
|
Effective
hedged
interest rate
2023
|
Current
|
|
|
|
|
€400m bond due November
2024
|
–
|
–
|
Fixed
0.950%
|
Fixed
3.60%
|
Non-current
|
|
|
|
|
€500m bond due May
2026
|
Fixed
0.875%
|
Fixed
2.66%
|
Fixed
0.875%
|
Fixed
2.80%
|
€850m bond due June
2027
|
Fixed
3.875%
|
Fixed
4.95%
|
Fixed
3.875%
|
Fixed
5.01%
|
€600m bond due October
2028
|
Fixed
0.500%
|
Fixed
2.12%
|
Fixed
0.500%
|
Fixed
2.23%
|
€600m bond due June
2030
|
Fixed
4.375%
|
Fixed
4.58%
|
Fixed
4.375%
|
Fixed
4.48%
|
£400m bond due June
2032
|
Fixed
5.000%
|
Fixed
5.19%
|
Fixed
5.000%
|
Fixed
5.20%
|
Average cost of
bond debt at year-end rates
|
|
3.96%
|
|
3.97%
|
The effective hedged interest rate
reflects the interest rate payable after the impact of interest due
from cross-currency swaps. The Group’s hedging strategy is to
hold foreign currency debt in proportion to foreign currency profit
and cash flows, which are mainly in euro and US dollar. As a
result, the Group has swapped a portion of the bonds it has issued
into US dollars, thus increasing the effective hedged interest
rate.
The Group considers the fair value
of other current liabilities to be equal to the carrying
value.
16. Provisions
for liabilities and charges
The Group has provisions for
termite damage claims, self-insurance, environmental, and other.
Provisions are recognised when the Group has a present obligation
as a result of past events, it is probable that an outflow of
resources will be required to settle the obligation, and the amount
is capable of being reliably estimated. If such an obligation is
not capable of being reliably estimated it is classified as a
contingent liability.
Future cash flows relating to these
obligations are discounted when the effect is material. The effect
of discounting environmental provisions and other provisions is not
considered to be material due to the low level of expected future
cash flows. Termite damage claim provisions and self-insurance
provisions are discounted, and the majority of these provisions are
held in the US. The discount rate used is based on US government
bond rates, and was 4.48%–5.25% (2023:
3.88%–5.25%).
|
Termite damage
claims£m
|
Self-insurance£m
|
Environmental£m
|
Other£m
|
Total£m
|
At 1 January
2023
|
321
|
165
|
16
|
12
|
514
|
Exchange
differences
|
(14)
|
(8)
|
(1)
|
1
|
(22)
|
Additional
provisions
|
15
|
56
|
3
|
7
|
81
|
Used during the
year
|
(73)
|
(44)
|
(2)
|
(7)
|
(126)
|
Unused amounts
reversed
|
–
|
(8)
|
–
|
(3)
|
(11)
|
Acquisition of companies and
businesses
|
–
|
–
|
–
|
1
|
1
|
Unwinding of discount on
provisions
|
11
|
3
|
–
|
–
|
14
|
At 31 December
2023
|
260
|
164
|
16
|
11
|
451
|
|
|
|
|
|
|
At 1 January
2024
|
260
|
164
|
16
|
11
|
451
|
Exchange
differences
|
3
|
1
|
–
|
–
|
4
|
Additional
provisions
|
20
|
98
|
1
|
8
|
127
|
Used during the
year
|
(68)
|
(81)
|
(3)
|
(9)
|
(161)
|
Unused amounts
reversed
|
(12)
|
–
|
(1)
|
(2)
|
(15)
|
Acquisition of companies and
businesses
|
–
|
–
|
–
|
2
|
2
|
Unwinding of discount on
provisions
|
10
|
1
|
–
|
–
|
11
|
At 31 December
2024
|
213
|
183
|
13
|
10
|
419
|
|
2024Total£m
|
2023Total£m
|
Analysed as
follows:
|
|
|
Non-current
|
304
|
357
|
Current
|
115
|
94
|
Total
|
419
|
451
|
Termite damage
claims
The Group holds provisions for
termite damage claims covered by contractual warranties. Termite
damage claim provisions are subject to significant assumptions and
estimation uncertainty. The assumptions included in valuing termite
provisions are based on an estimate of the volume and value of
future claims (based on historical and forecast information),
customer churn rates, and discount rates. These provisions are
expected to be substantially utilised within the next 16 years at a
declining rate. The trend of volume and value of claims is
monitored and reviewed over time (with the support of external
advisors) and as such the value of the provision is also likely to
change.
The Group’s provision relates
to legacy claims (from the period prior to the acquisition of
Terminix), estimated at £197m (2023: £247m); and new
customer claims, estimated at £16m (2023: £13m). The
sensitivity of the legacy claims liability balance to changes in
the inputs is illustrated as follows:
●
|
Discount rate – The exposure to
termite damage claims is largely based within the United States,
therefore measurement is based on a seven-year US bond risk-free
rate. During 2024, interest rates (and therefore discount rates)
have increased. Rates could move in either direction and management
has modelled that an increase/decrease of 50 bps in yields would
decrease/increase the provision by £5m (2023: £8m). Over
the 12 months to 31 December 2024, seven-year risk-free rate yields
have increased 60 bps from 3.88% to 4.48% (2023: decrease 15
bps).
|
●
|
Claim value – Claim value
forecasts have been based on the latest available historical
settled Terminix claims. Claims values are dependent on a range of
inputs including labour cost, materials costs (e.g. timber),
whether a claim becomes litigated or not, and specific
circumstances including contributory factors at the premises.
Management has used an average of claim costs for the last 12
months for each material category of claim, adjusted where
necessary to account for ageing of claims, to determine an estimate
for costs per claim. Recent fluctuations in input prices (e.g.
timber prices) means that there is potential for volatility in
claim values and therefore future material changes in provisions.
Management has modelled that an increase/decrease of 5% in claim
values would increase/decrease the provision by £9m (2023:
£15m). Over the 12 months to 31 December 2024, as a result of
accelerating the cleardown of legacy longstanding claims and other
macroeconomic factors, in-year costs per claim rose by c.40% (2023:
32%). This is not representative of management’s expectations
of future costs as ageing of claims, which drives an increased cost
per claim, has reduced significantly in recent months and is
expected to continue to improve.
|
●
|
Claim rate – Management has
estimated claim rates based on statistical historical incurred
claims. Data has been captured to establish incidence curves that
can be used to estimate likely future cash outflows. Changes in
rates of claim are largely outside the Group’s control and
may depend on litigation trends within the US and other external
factors, such as how often customers move property and how well
they maintain those properties; however, management actions can
prevent claims from becoming litigated and hence more costly. These
factors cause estimation uncertainty that could lead to material
changes in provision measurement. Management has modelled that an
increase/decrease of 5% in overall claim rates would
increase/decrease the provision by £9m (2023: £15m),
accordingly. Over the 12 months to 31 December 2024, claim rates
fell by c.24% (2023: fell 7%).
|
●
|
Customer churn rate – If customers
choose not to renew their contracts each year, then the assurance
warranty falls away. As such there is sensitivity to the assumption
on how many customers will churn out of the portfolio of customers
each year. Data has been captured and analysed to establish
incidence curves for customer churn, and forward-looking
assumptions have been made based on these curves. Changes in churn
rates are subject to macroeconomic factors and to the performance
of the Group. A 1% movement in customer churn rates, up or down,
would change the provision by £7m down or up (2023:
£11m), accordingly. On average over the last 10 years churn
rates have moved by +/– c.2.0% per annum (2023:
+/-1.8%).
|
Self-insurance
The Group purchases external
insurance from a portfolio of international insurers for its key
insurable risks. In order to help mitigate the cost of external
insurance, the Group self-insures a level of cover on its major
insurance policies. Self-insurance provisions represent obligations
for open claims, and also incurred but not reported (IBNR) losses.
External actuaries are used to help management estimate the
provisions held at the balance sheet date. Due to the nature of the
claims, the timing of utilisation of these provisions is
uncertain.
Environmental
The Group owns, or formerly owned,
a number of properties in Europe and the US where environmental
contamination is being managed. These issues tend to be complex to
determine and resolve and may be material, although it is often not
possible to accurately predict future costs of management or
remediation reliably. Provisions are held where liability is
probable and costs can be reliably estimated. Contingent
liabilities exist where the conditions for recognising a provision
under IAS 37 have not been met. The Group monitors such properties
to determine whether further provisions are necessary. The
provisions that have been recognised are expected to be
substantially utilised within the next five
years.
Other
Other provisions principally
comprise amounts required to cover obligations arising and costs
relating to disposed businesses and restructuring costs. Other
provisions also includes costs relating to onerous contracts and
property dilapidations settlements. Existing provisions are
expected to be substantially utilised within the next five
years.
17. Share
capital
During the year, 2,000,000 new
shares were issued in relation to employee share
schemes.
|
2024
£m
|
2023
£m
|
Issued and fully
paid
|
|
|
At 31 December 2024 –
2,524,539,885 shares (2023: 2,522,539,885)
|
25
|
25
|
18. Post balance
sheet events
There have been no significant post
balance sheet events affecting the Group since 31 December
2024.
19. Legal
statements
The financial information for the
year ended 31 December 2024 contained in this preliminary
announcement has been approved by the Board and authorised for
release on 6 March 2025.
The financial information in this
statement does not constitute the Company’s statutory
accounts for the years ended 31 December 2024 or 2023. The
financial information for 2023 and 2024 is derived from the
statutory accounts for 2023 (which have been delivered to the
registrar of companies) and 2024 (which will be delivered to the
registrar of companies following the AGM in May 2025). The auditors
have reported on the 2023 and 2024 accounts; their report was (i)
unqualified, (ii) did not include a reference to any matters to
which the auditors drew attention by way of emphasis without
qualifying their report and (iii) did not contain a statement under
section 498 (2) or (3) of the Companies Act
2006.
The statutory accounts for 2024 are
prepared in accordance with UK-adopted International Accounting
Standards and International Financial Reporting Standards (IFRSs)
as issued by the International Accounting Standards Board (IASB).
The accounting policies (that comply with IFRS) used by Rentokil
Initial plc (“the Group”) are consistent with those set
out in the 2023 Annual Report. A full list of accounting policies
will be presented in the 2024 Annual Report. For details of new
accounting policies applicable to the Group in 2024 and their
impact please refer to Note 1.
20. 2024 Annual
Report
Copies of the 2024 Annual Report
will be sent to shareholders who have elected to receive hard
copies on or around 26 March 2024 and will also be available
from the Company’s registered office by contacting the
Company Secretariat (secretariat@rentokil-initial.com) and at
www.rentokil-initial.com in PDF format.
21. Financial
calendar
The Company's Annual General
Meeting will be held at, and be broadcast from, the Company's
offices at Compass House, Manor Royal, Crawley, West Sussex, RH10
9PY from 2pm on 7 May 2024. Shareholders should refer to the Notice
of Meeting and the Company's website at
www.rentokil-initial.com/agm for further information on the
AGM.
22.
Responsibility statements
The Directors consider that the
Annual Report, which includes the Financial Statements, complies
with the Disclosure Guidance and Transparency Rules of the United
Kingdom’s Financial Conduct Authority in respect of the
requirement to produce an annual financial
report.
Each of the Directors, whose names
and functions are set out in the 2024 Annual Report, confirms that,
to the best of their knowledge:
●
|
the Group Financial Statements,
which have been prepared in accordance with UK-adopted
International Accounting Standards and International Reporting
Financial Standards as issued by the International Accounting
Standards Board, give a true and fair view of the assets,
liabilities, financial position and profit of the
Group;
|
●
|
the Company’s Financial
Statements, which have been prepared in accordance with United
Kingdom Accounting Standards, comprising FRS 101 ‘Reduced
Disclosure Framework’, give a true and fair view of the
assets, liabilities, financial position and profit of the Company;
and
|
●
|
the Annual Report includes a fair
review of the development and performance of the business and the
position of the Group, together with a description of the principal
risks and uncertainties that it faces.
|
By Order of the
Board
Andy Ransom
Chief
Executive
6 March 2025
Cautionary
statement
In order to utilise the ‘safe
harbour’ provisions of the U.S. Private Securities Litigation
Reform Act of 1995 (the “PSLRA”) and the general
doctrine of cautionary statements, Rentokil Initial plc (“the
Company”) is providing the following cautionary statement:
This communication contains forward-looking statements within the
meaning of the PSLRA. Forward-looking statements can sometimes, but
not always, be identified by the use of forward-looking terms such
as “believes,” “expects,”
“may,” “will,” “shall,”
“should,” “would,” “could,”
“potential,” “seeks,” “aims,”
“projects,” “predicts,” “is
optimistic,” “intends,” “plans,”
“estimates,” “targets,”
“anticipates,” “continues” or other
comparable terms or negatives of these terms and include statements
regarding Rentokil Initial’s intentions, beliefs or current
expectations concerning, amongst other things, the results of
operations of the Company and its consolidated entities
(“Rentokil Initial” or “the Group”)
(including preliminary results for the year ended 31 December
2024), financial condition, liquidity, prospects, growth,
strategies and the economic and business circumstances occurring
from time to time in the countries and markets in which Rentokil
Initial operates. Forward-looking statements are based upon current
plans, estimates and expectations that are subject to risks,
uncertainties and assumptions. Should one or more of these risks or
uncertainties materialise, or should underlying assumptions prove
incorrect, actual results may vary materially from those indicated
or anticipated by such forward-looking statements. The Company can
give no assurance that such plans, estimates or expectations will
be achieved and therefore, actual results may differ materially
from any plans, estimates or expectations in such forward-looking
statements. Important factors that could cause actual results to
differ materially from such plans, estimates or expectations
include: the Group’s ability to integrate acquisitions
successfully, or any unexpected costs or liabilities from the
Group’s disposals; difficulties in integrating, streamlining
and optimising our IT systems, processes and technologies,
including artificial intelligence technologies; the Group’s
ability to attract, retain and develop key personnel to lead the
business; the availability of a suitably skilled and qualified
labour force to maintain the Group’s business; cyber security
breaches, attacks and other similar incidents, as well as
disruptions or failures in the Group's IT systems or data security
procedures and those of our third-party service providers;
weakening general economic conditions, including changes in the
global job market or decreased consumer confidence or spending
levels, especially as they may affect demand from the Group's
customers; inflationary pressures, such as increases in wages, fuel
prices and other operating costs; the Group’s ability to
implement its business strategies successfully, including achieving
its growth objectives; the Group’s ability to retain existing
customers and attract new customers; the highly competitive nature
of the Group’s industries; extraordinary events that impact
the Group’s ability to service customers without
interruption, including a loss of its third-party distributors; the
impact of environmental, social and governance (“ESG”)
matters, including those related to climate change and
sustainability, on the Group’s business, reputation, results
of operations, financial condition and/or prospects; supply chain
issues, which may result in product shortages or other disruptions
to the Group’s business; the Group’s ability to protect
its intellectual property and other proprietary rights that are
material to the Group’s business; the Group’s reliance
on third parties, including third-party vendors for business
process outsourcing initiatives, investment counterparties, and
franchisees, and the risk of any termination or disruption of such
relationships or counterparty default or litigation; any future
impairment charges, asset revaluations or downgrades; failure to
comply with the many laws and governmental regulations to which we
are subject or the implementation of any new or revised laws or
regulations that alter the environment in which we do business, as
well as the costs to us of complying with any such changes and the
risk of related litigation; termite damage claims and lawsuits
related thereto and any associated impacts on the termite
provision; the Group’s ability to comply with safety, health
and environmental policies, laws and regulations, including laws
pertaining to the use of pesticides; any actual or perceived
failure to comply with stringent, complex and evolving laws, rules,
regulations and standards in many jurisdictions, as well as
contractual obligations, including data privacy and security, and
any litigation related to such actual or perceived failures; the
identification of material weaknesses in the Group's internal
control over financial reporting within the meaning of Section 404
of the Sarbanes-Oxley Act; changes in tax laws and any
unanticipated tax liabilities; adverse credit and financial market
events and conditions, which could, among other things, impede
access to or increase the cost of financing; the restrictions and
limitations within the agreements and instruments governing our
indebtedness; a lowering or withdrawal of the ratings, outlook or
watch assigned to the Group’s debt securities by rating
agencies; an increase in interest rates and the resulting increase
in the cost of servicing the Group’s debt; and exchange rate
fluctuations and the impact on the Group’s results or the
foreign currency value of the Company’s ADSs and any
dividends. The list of factors presented here is representative and
should not be considered to be a complete statement of all
potential risks and uncertainties. Unlisted factors may present
significant additional obstacles to the realisation of
forward-looking statements. The Company cautions you not to place
undue reliance on any of these forward-looking statements as they
are not guarantees of future performance or outcomes and that
actual performance and outcomes, including, without limitation, the
Group’s actual results of operations, financial condition and
liquidity, and the development of new markets or market segments in
which the Group operates, may differ materially from those made in
or suggested by the forward-looking statements contained in this
communication. Except as required by law, Rentokil Initial assumes
no obligation to update or revise the information contained herein,
which speaks only as of the date hereof.
Additional information concerning
these and other factors can be found in Rentokil Initial’s
filings with the U.S. Securities and Exchange Commission
(“SEC”), which may be obtained free of charge at the
SEC’s website, http:// www.sec.gov, and Rentokil
Initial’s Annual Reports, which may be obtained free of
charge from the Rentokil Initial website,
https://www.rentokil-initial.com
No statement in this announcement
is intended to be a profit forecast and no statement in this
announcement should be interpreted to mean that earnings per share
of Rentokil Initial for the current or future financial years would
necessarily match or exceed the historical published earnings per
share of Rentokil Initial.
This communication presents certain
further non-IFRS measures, which should not be viewed in isolation
as alternatives to the equivalent IFRS measure, rather they should
be viewed as complements to, and read in conjunction with, the
equivalent IFRS measure. These include revenue and profit measures
presented at actual exchange rates (“AER” – IFRS)
and constant full year 2023 exchange rates (“CER”
– Non-GAAP). Non-IFRS measures include Adjusted Operating
Profit, Adjusted Profit Before Tax, Adjusted Profit After Tax,
Adjusted EBITDA, Adjusted Interest, Adjusted Earnings Per Share,
Free Cash Flow, Adjusted Free Cash Flow, Adjusted Free Cash Flow
Conversion, Adjusted Effective Tax rate and Organic Revenue.
Adjusted Operating Profit represents the performance of the
continuing operations of the Group (including acquisitions), and
enables the users of the accounts to focus on the performance of
the businesses retained by the Group, and that will therefore
contribute to the future performance. Adjusted Operating Profit and
Adjusted profit before tax exclude certain items that could distort
the underlying trading performance. The Group’s internal
strategic planning process is also based on these measures, and
they are used for incentive purposes. These measures may not be
calculated in the same way as similarly named measures reported by
other companies.
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date: 06 March
2025
|
RENTOKIL INITIAL PLC
|
|
/s/ Rachel
Canham
|
|
Name: Rachel
Canham
|
|
Title: Group
General Counsel and Company Secretary
|
|
|
Rentokil Initial 2005 (PK) (USOTC:RKLIF)
Graphique Historique de l'Action
De Fév 2025 à Mar 2025
Rentokil Initial 2005 (PK) (USOTC:RKLIF)
Graphique Historique de l'Action
De Mar 2024 à Mar 2025